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ABSTRACT 
 
Acute brain trauma and ischemia are severe injuries that have no adequate 
treatment to date. In vivo two-photon microscopy allows studying longitudinally 
the process of injury development and brain recovery. This thesis summarizes the 
work on: i) animal model of acute brain injury (Study I) and role of extracellular 
matrix in neuronal recovery and plasticity (Study II), ii) investigation of 
mitochondria during physiological/pathological Ca2+ elevations in vitro (Study III) 
and further implementation of quantitative microscopic analysis of neuronal 
mitochondrial morphology in vivo (Study IV), iii) mitochondrial damage and 
recovery in animal models of acute neurodegenerative disorders in the neocortex 
of anesthetized mice (Study V), iv) a novel approach for awake head-fixed 
recordings (Study VI). The results described in this work provide novel approaches 
for intravital morphological analysis of neurons and of their mitochondria, 
increase our understanding of pathogenesis after traumatic and ischemic injury in 
neocortex of rodents, and enable the development of novel therapies for CNS 
injuries. 
 
ABSTRAKTI 
Sekä akuuttinen aivoisten trauma että iskemiä ovat eritäin vakavia vammoja, ja 
keinoja niiden parantamiseen ovat puutelisiä. Vammojen kehittämisen ja aivoisten 
parantamisen mekanismit tutkimisen on mahdollinen tuplafotoni mikroskopian 
avulla. Tämä väitöskirja on perustettu kuudella julkaisutella ja kertoo viidestä 
asiasta: i) akuuttinen aivoisten trauman koe-eläin malli (Tutkimus I) ja 
soluväliaisten matriksin rooli hermosolujen parantamisessa ja plastisuudessa 
(Tutkimus II), ii) in vitro tutkimus mitokondrian roolista 
fysiologiassa/patofysiologiassa kalsiumin nostamisessa (Tutkimus III) sekä in vivo 
mitokondria morfologian analysointi keinoen kehittäminen (Tutkimus IV), iii) 
mitokondrian vahingoittaminen ja parantaminen neurodegenerativisten 
sairauksien malleissa hiirten neokorteksissa anestesian alla (Tutkimus V), iv) uusi 
keino in vivo rekisteröintien varten ilman anestesia (Tutkimus VI). Tutkimuksen 
tulokset antoivat uudet keinot mitokondrian analysointien hermosoluissa, ne 
parantavat myös meidän ymmärtäminen post-traumateisten ja post-iskemiään 
vammojen hiirten neokorteksissa.  Tutkimustulokset tulevat merkittävällä tavalla 
lisäämään ymmärrystä aivohalvauksen patofysiologiasta ja edistää uusien 
terapiamahdollisuuksien löytämistä. 
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REVIEW OF LITERATURE 
1. The Brain in traumatic and ischemic injury 
1.1. Clinical background 
 
Traumatic and ischemic brain injuries are among the leading causes of mortality 
and long-term disability and have been identified as important worldwide public 
health problems that pose an enormous socio-economic burden. 
Traumatic brain injury (TBI) is caused by the impact of external physical forces 
that produce temporal or permanent impairment of cognitive abilities and/or 
physical functioning. The leading causes of TBI are motor vehicle accidents, falls, 
assaults, job-related injuries and sport activities. Each year over 10 million people 
are affected by TBI, around 1.5 million of those die, it is the number one cause of 
coma and among the survivors it commonly causes lifelong disabilities, making 
dramatic personal impact and society load (Roozenbeek, Maas, and Menon 2013). 
In most epidemiologic studies there are three age related peaks: in early 
childhood (under the age of 5), in young adults (the most active population), and 
in the elderly (over the age of 75). Each year, in the US alone, the annual 
economic burden from TBI is more than $60 billion. A cumulative result of past TBI 
shows that a considerable proportion of the population is suffering from 
permanent TBI-related disability. Currently, no pharmacological treatments have 
been proven to protect against the harmful consequences of TBI. 
Stroke is the second most common cause of death and a leading cause of 
disability in adults worldwide (WHO, 2013). Stroke can be caused by a blockage of 
blood flow to the brain in the case of ischemic stroke or a blood vessel rupture in 
the case of hemorrhagic stroke and in both cases it is characterized by an abrupt 
loss of brain function. Approximately 17 million people have strokes each year and 
around 6.2 of those die shortly after the stroke. Two thirds of strokes occur in 
people over 65 years old. The estimated cost of strokes is more than $36.5 billion 
per year, in the US alone, 33 million of people live with stroke in their anamnesis 
(Feigin et al. 2013; Go et al. 2014). Unlike TBI, early thrombolysis or 
thrombectomy are available for ischemic stroke patients as treatments. The 
thrombolytic treatments with tissue plasminogen activator (tPA) has been proven 
effective in treating stroke when given within 4.5 hours after ischemic onset 
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(Cronin 2010). Unfortunately, this therapy is available only for a limited group of 
patients due to the narrow therapeutic time window (which is often missed) 
(Tansy and Liebeskind 2013). Although stroke and traumatic brain primarily affect 
different age groups, both result in a significant number of individuals with long-
term or even permanent deficits. 
Traumatic and ischemic injures of the brain arise from very different initial events. 
TBI generally results from external mechanical impact and in a minority of cases 
from an object penetrating the skull and meninges. The damage after TBI can be 
localized to the sites of penetration/impact (open/closed-head type of TBI) or can 
be more widespread if fragments of bone enter the brain or the brain is slammed 
inside the skull. These initial events of TBI cause direct and immediate damage 
that may lead to disability or death. The three generally accepted assessment 
approaches are: the Glasgow Coma Scale, Post-Traumatic Amnesia and Loss of 
Consciousness, which are used to categorize the severity of TBI at the acute phase 
into mild, moderate and severe. The ratio of mild to moderate to severe traumatic 
brain injuries is estimated to be 22:1.5:1, so mild brain injuries represent the 
majority (from 75% to 95%) of cases (Andriessen, Jacobs, and Vos 2010). It is 
possible to segregate four major pathoanatomic consequences following TBI: 
hematomas, including epidural, subdural, and parenchymal, then contusions, 
subarachnoid hemorrhage, and diffuse axonal injury (Saatman et al. 2008) 
although they can be present together in different proportions. 
The classification of strokes is clearer and includes three major categories: 
ischemic, hemorrhagic stroke and transient ischemic attack (TIA). The most 
common form of stroke is ischemic, it constitutes about 87% of all cases (Go et al. 
2014). Ischemic stroke generally results from cerebral thrombosis, which is 
obstruction of a blood vessel by a blood clot forming locally and from cerebral 
embolism, which is a blood clot formed in the heart or large arteries of upper 
chest and neck. In rare cases ischemic stroke results from systemic hypoperfusion 
commonly due to heart failure. Ischemic stroke can be focal or global as well as 
permanent or transient. The duration and localization of ischemic stroke and size 
of infarction strongly affect the prognosis of clinical outcomes. Near 75% of 
ischemic stroke survivors’ disabilities’ are severe enough to reduce their 
employability. Hemorrhagic stroke is induced by bleeding from a ruptured vessel 
and represents about 10% of all cases. Aneurysms and arteriovenous 
malformations are major blood vessel diseases that cause hemorrhagic stroke. A 
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greater risk of death arises from bleeding, however it deprives affected tissues of 
a blood supply and creates pressure on the brain. Despite this, the consequences 
can be less severe and recovery may be more complete for a person who survives 
hemorrhage than for those who experience ischemic stroke. Transient ischemic 
attack is frequently called a mini-stroke, it is caused by transient episodes of 
cerebral thrombosis that induces neurologic dysfunction caused by ischemia 
without acute infarction. When TIA is over and the clot dissolved, it usually causes 
no permanent injury to the brain (Siket and Edlow 2013). However, it should be 
taken into account that about one third of patients after TIA experience ischemic 
stroke within a year. 
The outcomes from stroke and TBI depend on two substantially different 
mechanisms: primary damage, occurring at the moment of impact, and secondary 
damage that represents consecutive pathological processes initiated at the 
moment of injury with delayed clinical presentation. The primary impact in 
traumatic and ischemic injures initiates a wide range of secondary injury 
mechanisms that critically participate in diseases pathogenesis. The severity of the 
secondary mechanisms of TBI and ischemic stroke directly depends upon injury 
severity or the location of the primary impact. Secondary injury in TBI and 
ischemic stroke are similar to some extent and can lead to a spectrum of 
pathological changes that substantially influence the patients’ health statuses. 
The current abilities to block TBI or ischemic stroke-induced events are very 
limited. Despite this unmet clinical need and considerable investments, the 
current failure rate in clinical trials of drugs in this area is catastrophically high, 
with nine out of ten trials either failing or being aborted. Novel pharmacological 
therapies such as anti-oxidant treatments, glutamate blockers and physiotherapy, 
such as constraint-induced movement therapy, have shown promising 
effectiveness in pre-clinical studies, but have limited clinical success or are not 
widely used. This situation imposes an enormous financial burden on taxpayers 
and forces major pharmaceutical companies to withdraw from drug discovery 
against traumatic and ischemic injury. Further research has to be performed to 
expand our understanding of the complex pathophysiology of these injuries with 
the aim of developing novel drugs and effective therapeutic strategies for patients 
suffering from these devastating diseases. 
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1.2. Consequences of traumatic and ischemic injury 
1.2.1. Functional deficit 
Survivors after traumatic and ischemic injury experience physical, cognitive and 
psychosocial deficit that disturb their emotional, mental and social performance in 
their daily lives (Ponsford et al. 2014). During recovery after TBI and stroke the 
wide spectrum of disorders that affect life quality can occur and last for a long 
period or even persist permanently. The disorders faced by survivors just after 
injury strongly depend on the duration and location of the brain damage, its 
severity and the medical support received post-injury. Long-term post-injury 
outcomes depend on multiple factors, such as pre-injury socio-demographic 
characteristics, injury severity variables, post-injury personal factors and post-
injury environmental factors. 
Pre-injury risk factors such as biological (non-modifiable factors) - age, gender, 
genetic predisposition, race/ethnicity and familial history; physiological 
factors(modifiable) - hypertension, carotid disease, diabetes, dyslipidemia 
(elevated cholesterol and triglycerides), sleep apnea, intracranial atherosclerosis, 
transient ischemic attack, valvular heart disease, atrial fibrillation, aortic arch 
atheroma, sickle cell disease, depression, brain infections and chronic 
inflammation; lifestyle factors (modifiable) - obesity, physical inactivity, smoking, 
heavy drinking, high sodium intake, as well as their comorbidity are known from 
epidemiological studies to strongly contribute to prognosis for recovery following 
stroke and TBI (Ankolekar et al. 2012; Kuklina et al. 2012). Relatively effective 
preventive strategies are available to control certain risk factors has been 
established in recent years (Kernan et al. 2014). In some cases application of risk 
assessment tools can reduce as much as 80% of all recurrent strokes. However, 
risk factors often co-occur in individual patient, this complexity makes 
development and implementation of optimal prevention strategy a challenging 
task. 
Several indicators are used to predict long-term outcomes in TBI and stroke 
survivors during the first few weeks and months after the injury. The location and 
size of the infarct determines the type of impairment to some extent since certain 
areas of the brain control specific functions. For example, brain stem damage 
caused by TBI can affect vegetative functions like breathing, swallowing, blood 
pressure and heart rate, whereas ischemic stroke that affected vascular territory 
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in the frontal lobe can change survivor’s emotional responses and judgments on 
environment and daily activities and affect memories and understanding of 
abstract concepts. There are three general types of impairment that can arise 
following stroke and TBI: physical, cognitive and emotional/behavioral deficits. 
The interactions between post-injury deficits are complex and unfortunately 
understood only partially. One of probable consequences of TBI and ischemic 
stroke is physical weakness. Musculoskeletal perversions that affect mobility are 
the most prevalent symptoms and they are present in up to 79% of stroke 
patients (Cheng, Leys, and Esquenazi 2013) and in 40% of patients after TBI (Jang 
2009). The neurological damage affects multiple systems with impacts on motor 
functions that result in mobility loss, hemiparesis, spasticity, gait disturbance, 
skilled movement loss, apraxia, ataxia, involuntary movement and poor balance. 
In most cases patients suffer from more than one physical disability. Around 60% 
of stroke patients show sensory deficits (Schabrun and Hillier 2009) that disturb 
their abilities to perceive and discriminate sensations of pain, temperature, 
pressure and vibration, as well as their abilities to accurately locate body parts in 
space. Moto-sensory deficits determine just a portion of post-injury impairments. 
Commonly, in TBI and ischemic stroke patients other physical problems such as 
incontinence, speech and swallowing disorders can occur. Often epilepsy becomes 
a residual disorder in the post-injury period and in some cases can persist for the 
rest of the patients’ lives. The frequency of seizures ranges between 2.3% and 
14% in ischemic stroke (Menon and Shorvon 2009) and from 2% in population-
based studies to 14–30% in patients with severe TBI (Christensen 2012). Seizures 
in the setting of TBI and ischemic stroke will furthermore worsen the prognosis of 
injury. 
Cognitive deficits are a common consequence of traumatic and ischemic injury 
and its prevalence ranges from 20% to 80% of the survivors. Memory and 
learning, attention and communication are to a greater or lesser extent affected 
by amnesia, agnosia, aphasia, apraxia, dysopsia, executive dysfunction and mood 
disorders. Memory deficits are the most enduring cognitive impairment and are 
particularly difficult to treat. The underlying mechanisms of cognitive impairment 
are not well known, however pathogenesis is likely to involve vascular cognitive 
impairment by itself or by Alzheimer’s disease (AD). There is evidence from 
autopsy studies suggesting that around half of the patients with cognitive deficit 
have attributions from both (Jellinger 2007). Many patients develop mild cognitive 
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impairment and some meet the clinical criteria of dementia. In particular, 
approximately 10% of patients develop new dementia after their first stroke, 
whereas 30% developed dementia after a recurrent stroke (Pendlebury and 
Rothwell 2009). 
The survivors that face physical or/and cognitive impairments usually experience 
frustration and depression, or in case of TBI - post-traumatic stress disorder 
(PTSD). Depression is found in 31% of patients in the acute period after a stroke 
(Hackett and Pickles 2014). The frequency of PTSD varies dramatically along 
epidemiological studies, mainly due to debates that PTSD and TBI do not co-occur 
(Harvey et al. 2003). In general, PTSD ranges from 3 to 30% in civilian patients and 
from 12% to 89% in military patients and veterans (Bahraini et al. 2014). Mood 
disorders are individually complex and when combined with stroke and TBI they 
create significant assessment challenges and lead to worse cognitive and physical 
outcomes (van de Port et al. 2006). Depression and PTSD need to be carefully 
diagnosed and treated accordingly in order to improve functional recovery. 
Recently, a new aspect of antidepressant medications has arisen after fluoxetine 
(a selective serotonin reuptake inhibitor) was shown to improve the functional 
recovery of patients with hemiplegic stroke (Gainotti et al. 2001; Paolucci 2013). 
This opens up a new field in post-injury rehabilitation through a neuronal target. 
During rehabilitation, therapeutic modalities and exercise, along with medication 
interventions are targeted on lingering symptoms including motor and cognitive 
deficits and aimed to improve the functional status of the survivors so that they 
can independently perform personal care and regular daily activities and ideally 
can return to work and other social interactions. At present, post-injury 
rehabilitation is realized by the support of multidisciplinary teams in 
neurovascular units for stroke or by neuroscience units for TBI that organize 
packages of individualized care. However, neuropsychological and physical deficits 
are usually addressed in the rehabilitation setting as separate issues. Typically, 
more attention is given to physical and occupational rather than cognitive 
therapy. There are several task-specific and practice-based therapies that are 
designed to boost mobility, coordination and durability. One of them is constraint-
induced movement therapy - a treatment for mild and moderate upper extremity 
motor dysfunction and is often beneficial for acute or sub-acute stroke patients, 
although the effect does not persist in some cases and a limited number of clinical 
studies has been carried out in TBI (Thrane et al. 2014). Another rehabilitation 
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therapy is functional electrical stimulation aimed to contract weakened muscles in 
a precise manner in order to resemble functional tasks. Clinical studies have 
shown that this therapy can prevent or reduce shoulder subluxation early after 
stroke, but it does not reduce pain or improve upper arm motor function 
(Vafadar, Côté, and Archambault 2015). Electromyogram biofeedback is also used 
to improve affected arms via the delivery of auditory or visual stimuli from 
electrodes placed on the skin. However, the long-term efficacy of this therapy is 
unclear. At present there are many physiotherapies for individuals with TBI and 
stroke that recruit a high variability of methods with different training intensities, 
some of them have demonstrated beneficial outcomes on motor function even 
with a negative effect on tone and increased pain (Saunders, Greig, and Mead 
2014). For example, motor recovery can be improved with clinically proven 
effectiveness by meaningful task-specific training (Arya et al. 2012). It can be 
followed with botulinum toxin A administration in selected groups of patients that 
have developed spasticity (Teasell et al. 2012). 
So far, there is no treatment with clearly proved efficacy for post-stroke or post-
TBI cognitive impairment. Some of the anti-dementia treatments like 
cholinesterase inhibitor, donepezil (Rockwood et al. 2013) or NMDA receptor 
antagonists like memantine (Wilcock 2003) have been shown to improve some 
cognitive functions significantly, but due to the controversial results in the 
preclinical and clinical studies, further research is needed to define the efficacy of 
these treatments for trauma or ischemia induced cognitive deficits. However, 
there are currently several possible treatments undergoing preclinical trials. Some 
of them attempt to restore reduced cognition, others try to overcome or 
compensate for reduced function.  
Rehabilitation after traumatic and ischemic injuries is a complex process that is 
now lacking adequate management or well-timed therapy and suffers from the 
accessibility of neurorehabilitation services (Mendelow et al. 2008). There are 
many questions concerning the treatment of stroke and TBI patients which have 
not been studied yet. A better understanding of injury mechanism and recovery 
will promote the development of rehabilitation systems in a more logical and 
targeted manner. 
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1.2.2. Pathophysiology of stroke and TBI 
There have been many neuropathological studies on autopsy or postmortem 
samples that provide clinico-pathological correlations in patients following stroke 
or TBI. Clinical examination of the primary injury was reported for the first time 
after the advent of X-ray computed tomography (Gudeman et al. 1979). A major 
contribution to our understanding of brain pathology after the injury has been 
provided by neuroimaging, including computed tomography (CT) and magnetic 
resonance imaging (MRI) (Lövblad and Baird 2006), and electrophysiological 
approaches like quantitative, topological electroencephalography (EEG) (Haneef 
et al. 2013), magnetoencephalography and magnetic source imaging. In the last 
decade, positron emission tomography (PET), single proton emission tomography, 
functional and diffusion-weighted MRI (DWI) have been used to identify 
functional correlations between the structural changes (Hunter et al. 2012; 
Schaefer, Grant, and Gonzalez 2000). Transcranial Doppler and angiography with 
contrast in CT and MRI provide additional data on vessel abnormalities, including 
narrowing or occlusion, embolus, atherosclerosis, arteriovenous malformations 
and aneurysms, and regions with low cerebral blood flow (CBF). These methods 
are especially critical in understanding the progression of TBI (Bouzat, Oddo, and 
Payen 2014). Laboratory tests of blood, urine and cerebrospinal fluid samples 
have allowed the identification of a large number of injury biomarkers 
(Zetterberg, Smith, and Blennow 2013). This palette of approaches helps to 
identify key pathological consequences and also drive clinical diagnosis, prognosis 
and acute treatment decisions (von Kummer, Dzialowski, and Gerber 2015). 
Human brain tissue typically suffers from multiple pathologies following stroke 
and TBI. Propagation of injury in both cases arises from similar pathophysiological 
cascades. Many of the cellular and molecular responses are due to common 
secondary injuries, such as ischemia, rather than reflecting the primary tissue 
response, such as mechanical axonal damage (Silver, McAllister, and Yudofsky 
2011). Below is a description of the key encompassing factors of individual 
pathological processes seen in TBI and stroke. 
Contusion 
TBI results in a contusion when the region of injury receives kinetic energy from 
the primary impact that causes shearing of the tissues. This immediately ruptures 
cells in the injury region and microvessels (Kurland et al. 2012). On a CT scan, a 
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contusion generally appears as a hemorrhagic lesion, but it can be distinguished 
from a laceration or hematoma since the pia mater remains intact and blood is 
intermixed with brain tissue. Excitotoxicity and microvascular dysfunction are two 
main consequences of contusion. In the parallel to secondary injury, protective 
mechanisms are activated, but these are found to be improper, like the 
inflammatory response that serves to clear tissue debris, but begins to 
overproduce free radicals causing propagation of the tissue injury (O’Connell and 
Littleton-Kearney 2013). The main drivers of secondary injury that lead to 
functional deficits after contusion are: tissue ischemia and vasogenic edema, 
further contributing to extravasation. Additionally, loss of the structural integrity 
of surrounding microvessels induces in hemorrhagic progression of a contusion 
(HPC) - expansion of the hemorrhagic lesion. Approximately half of patients with 
contusions demonstrate HPC on serial CT scans within the first 12 hours or late in 
3–4 days after head trauma. HPC usually occurs after a patient’s hospitalization, 
so they are in clinical conditions where it is possible to prevent this conscience. 
Around 19% of patients with large contusions develop HPC that requires surgical 
decompression (Alahmadi, Vachhrajani, and Cusimano 2010). Novel treatments 
are needed to prevent HPC, but currently only a few molecular events have been 
suggested for progressive microvascular failure. Therefore, clinical solution for 
contusion would not appear in near-term outlook. 
Diffuse traumatic axonal injury 
While the pathophysiological consequences of TBI are heterogeneous, one of the 
most common processes occurring in 40-50% of TBI patients hospitalized with 
closed head injury is diffuse axonal injury (DAI) (Povlishock and Katz 2005). Axons 
appear to be especially vulnerable to injury and DAI can be detected in the corpus 
callosum, brainstem and in internal capsule (Silver, McAllister, and Yudofsky 
2011). Because of the low resolutions capacities of conventional CT and MRI, they 
cannot identify DAI. In the majority of cases, DAI is accompanied by small 
hemorrhages and can be predicted from CT scans or MRI images that are more 
sensitive to blood components. In the clinical setting, usage of the DWI mode of 
MRI now increases the diagnosis of DAI directly. Quantitative diffusion tensor 
tractography also looks promising (Bazarian et al. 2007), although still 
controversial (Ilvesmäki et al. 2014), for the acute and long-term follow-up of TBI 
patients with DAI. So far, conventionally diagnostic confirmation of DAI can be 
done by histopathological examination. Primary axotomy - axonal degeneration 
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induced by the primary impact, is considered to be a relatively rare event. Mainly 
DAI is initiated by perturbations in axonal transport and the cytoskeleton that 
result in axonal swelling followed by secondary disconnection and Wallerian 
degeneration. Previously, DAI has been suggested to appear immediately or 
within months after TBI, but recent clinical evidence has demonstrated that it can 
be delayed for years (Chen et al. 2009). DAI may have a role in mild cognitive 
impairment or dementia after TBI, because it can induce development of 
Alzheimer-like pathologies (Johnson, Stewart, and Smith 2012). Degenerated 
axons are one of the major therapeutic targets in TBI that potentially may 
ameliorate chronic neurodegeneration. 
Brain Edema 
Cerebral edema describes brain swelling following strokes and TBI. It is a major 
cause of long term disability and mortality. There are four major types of brain 
edema: i) cytotoxic - related to intracellular sustained water accumulation due to 
cellular injury; ii) vasogenic - extracellular water accumulation resulting from 
blood–brain barrier (BBB) breakdown; iii) osmotic- caused by imbalances between 
the blood and tissues; iv) and hydrocephalic edema/interstitial - related to an 
obstruction of cerebrospinal fluid outflow (Unterberg et al. 2004). Cytotoxic 
edema is cell swelling induced either singly or by combination of the following 
mechanisms: plasma membrane permeability to ions, failure of the ion-pumps, 
and sustained uptake of hyperosmotic solutes. Vasogenic edema is characterized 
by plasma protein enrichment resulting from increased permeability of the 
capillary induced by primary mechanic impact or ischemic stroke. Ischemic stroke 
and TBI induce both cytotoxic and vasogenic edema. However, it has been 
recognized that after TBI edema happens predominantly due to BBB disruption, 
since on CT scans initially hyperdense hemorrhagic lesions develop a hypodense 
halo around the hemorrhagic focus. However, this view has been criticized since 
contrast enhanced CT and MRI studies reveal only minimal or moderate BBB 
leakage (Bullock et al. 1990) and clinical data have revealed no evidence of BBB 
leakage within the first 24 hours after injury (Maeda et al. 2003), supporting the 
concept of cellular brain edema. During the initial 2–3 days following TBI or 
ischemic stroke brain edema can progress from the core and spread to healthy 
tissue. It remains a crucial factor in the acute phase because patients are at risk of 
developing secondary damage. It may increase intracranial pressure (ICP), 
decrease cerebral perfusion and brain oxygenation, and eventually lead to brain 
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herniation and patient death. Even today, brain edema is still treated only 
symptomatically. Surgical decompressive craniectomy or osmotherapy are used 
mainly to decrease ICP. The most common treatment strategy is administration of 
the osmodiuretics, mannitol and hypertonic saline, which have well-documented 
transient ICP-reducing effect. Nevertheless, there are strong side effects related 
to rebound increase in ICP after withdrawal, electrolyte disturbances and renal 
and pulmonary failure (Grände and Romner 2012). The outcome has been poorly 
studied, so it is only possible to speculate on the osmotherapy efficacy. In 
principle, brain edema by itself is reversible, but its treatment is still challenging. 
Blood brain barrier disruption 
One of unique features of brain vasculature is the BBB that maintain neuronal 
homeostasis via regulation of the brain parenchyma composition (Davson 1976). 
Endothelial cells with tight junctions and the ensemble of astrocytes, pericytes 
and microglia form a relatively stable structure that is continuously modified by 
different external and internal factors. BBB provides a barrier, restricts migration 
of blood cells into the brain and facilitates active transport across it. Dysfunction 
of BBB has been identified as a common feature in stroke and TBI patients that 
can occur immediately as a direct consequence of endothelial damage and/or sub-
acutely within several days (Schoknecht and Shalev 2012). BBB becomes 
permeable while brain edema progress, this facilitates immune cells and serum 
components entering the brain, thus promoting inflammation as well as ion 
imbalance that increases excitability and can lead to epileptogenesis (Schoknecht, 
David, and Heinemann 2014). From another side, BBB opening can trigger 
vasogenic edema and an increase of intracranial pressure, hence promoting 
secondary damage. The role of BBB dysfunction in acute pathophysiology of 
stroke and TBI is generally recognized, but there are only few studies highlighting 
its long-term effects. Assessment of BBB permeability is limited in hospitalized 
patients since it requires invasive techniques. Mainly it is monitored by the 
albumin quotient in samples collected simultaneously from the cerebrospinal fluid 
and serum (Reiber and Peter 2001). In addition, contrasting imaging techniques 
can provide mapping and progression of the permeability. At present, dynamic 
contrast-enhanced MRI and dynamic contrast-enhanced CT are used to detect 
BBB disruption. Both methods involve i.v. injection of the contrast agents  
gadolinium or iodinated contrast, and voxel-wise measurement over the time of 
the MR signal or attenuation coefficient in CT scans (Kassner, Mandell, and Mikulis 
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2011). They can predict relatively accurately and promptly the transformation of 
BBB leakage to cerebral hemorrhage. This happens in 30-40% of stroke patients 
and causes severe clinical outcomes (Balami et al. 2011). Thrombolytic treatment 
with tissue plasminogen activator is an additional risk. Although, contrast imaging 
provides an assessment of individual patient risk and allows the adjustment of 
clinical decisions in acute treatment, the development of new medications is still 
needed. Preventing BBB dysfunction in the acute phase after stroke and TBI is 
needed to increase the number of patients that can be treated with thrombolysis 
and minimize its adverse effects. 
Intracranial hemorrhage 
Intracranial hemorrhages are the least treatable and often the cause of fatal 
consequences after stroke and TBI. They can be epidural, subdural, subarachnoid 
or intracerebral. Clinical studies have reported that epidural hemorrhage rarely 
appears in stroke patients and can be seen in 0.2% to 4% of TBI cases, mainly after 
fracture of temporal bone that leads to laceration of middle meningeal artery or 
vein, striping the dura from the skull and blood clot formation. This type of 
hemorrhage causes only minimal direct damage to the brain; nevertheless it 
increases intracranial pressure and promotes compression on cortical blood 
vessels and on the brainstem. Therefore, decompressive craniectomy needs to be 
performed in time to prevent severe consequences (Evans 2006). Subdural 
hemorrhage has been reported in about 5% of all TBI patients with rupture of 
bridging veins that connect cortical veins with dural sinus or contusions with 
cortical vessel damage. The results of subdural hemorrhage are more extensive 
than in epidural hemorrhage, because there is no mechanical barrier for the blood 
and it can easily spread. Subarachnoid hemorrhage can be found in approximately 
5-6% of all stroke patients, mainly caused by a ruptured cerebral aneurysm or 
rarely by vascular malformation (Johnson et al. 1996) and it has been found in CT 
scans of 33-60% TBI cases (Greene et al. 1996). Investigations show similarities 
between traumatic and aneurysmal subarachnoid hemorrhage suggesting that a 
similar therapeutic approach can be beneficial. The main target for interventions 
is the vasospasm (Armin, Colohan, and Zhang 2006). If it is severe enough, it can 
impair cerebral blood flow and causes a secondary ischemic stroke. Currently only 
nimodipine, L-type voltage-gated calcium channel blocker with good blood–brain 
barrier permeability, has clinically proved its efficacy in treating vasospasm 
(Barker and Ogilvy 1996; Young et al. 2015). There are a few options to prevent 
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aneurysm re-bleeding and actually no agents to ameliorate the harmful effects of 
subarachnoid hemorrhage. Intracerebral hemorrhage, often called microbleeds, 
results in blood leaks from small vessels and capillaries is present in 5% of all stoke 
patients, two-thirds of whom had hypertension in their anamnesis (Sutherland 
and Auer 2006), and in 16% of TBI patients they are commonly present in their 
frontal and temporal lobes (Evans 2006). The clinical picture ranges from 
asymptomatic to fatal. It is one of the most disabling forms of hemorrhage. 
Damage mainly arises from mechanical brain injury caused by blood (Sutherland 
and Auer 2006). Treatment (if any) and prognosis of intracerebral hemorrhage 
strongly depends on its size (less than 10 mL – good recover; over 60 mL – coma 
or mortality) and location as well as the patient’s state. However, there are no 
specific therapies improving the outcome after intracerebral hemorrhage (Sahni 
and Weinberger 2007). 
Ischemia 
Pathophysiologically, ischemia is defined as a reduction in blood flow and appears 
in 87% of stroke and 30-60% of TBI patients. There are three major types of 
ischemic strokes: i) large-artery atherosclerosis, ii) cardioembolism, iii) small-
vessel occlusion (Adams et al. 1993). Clots usually tend to form at or near an 
atherosclerotic plaque. Sometimes plaque deposits can block the flow of blood by 
their growth that can obstruct the blood vessel lumen. In cases of transient 
ischemic attack clots tend to form at times when blood pressure is low during 
sleep or early in the morning. Embolic stroke is caused by clots that form in one 
part of the body and then breaks away and reaches an artery in the brain or a 
vessel leading to the brain. Clot formation can be directly induced by primary 
traumatic impact and secondary ischemic stroke can occur within hours of TBI. 
Normal CBF is approximately 50-60 ml/100g/min. In response to clotting, local 
vasodilatation, redirection of the blood to the collaterals and increased oxygen 
and glucose consumption try to compensate for the drop in CBF. However, a 60% 
reduction of CBF disturbs brain metabolism, depresses neuronal activity and 
induces functional silencing. A CBF of less than 10ml/100g/min results in 
irreversible neuronal injury. Notably, time is the critical component of the 
ischemic stroke progression since some cells may survive if interventions are 
implemented rapidly. The concept of an ischemic penumbra, arising from animal 
experiments by Astrup and co-authors (Astrup et al. 1977), has formed current 
approaches to acute ischemic stroke assessment. Accordingly, hypoperfused 
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tissue may be mapped by CBF thresholds into three regions: i) infarct (core), 
where irreversible necrosis happens; ii) oligemia - region where cells will survive 
even without reperfusion; iii) ischemic penumbra that may survive only with 
prompt reperfusion (Heiss 2000). Actually, as it has been demonstrated in clinical 
studies, the region with dysfunctional but still viable neurons is relatively large in 
the acute phase after a stroke (Woodruff et al. 2011). Without proper reperfusion 
the volume of the ischemic penumbra decreases with a corresponding increase in 
the size of the infarcted core. Since the publication in 1995 of the results from the 
National Institute of Neurological Disorders and Stroke trials on intravenous 
recombinant tPA for acute ischemic stroke (Troke and Roup 1995), the use of tPA 
has become standard therapy for patients within the first 4.5 hours of stroke 
onset  with a significant improvement in neurologic recovery. The tPA treatment 
does not affect the rate of mortality and systemic hemorrhages, but intracranial 
hemorrhage has occurred in 6.4% of the treated patients versus 0.6% in a placebo 
group. This poses an urgent clinical need to develop individual patient risk 
assessment. The CT scan is now obligatory to exclude the presence of a 
hemorrhage that would exclude the use of tPA. In addition, CT angiogram can be 
used to identify large vessel stenosis or occlusion, MRI – for visualization of 
possible infarcted areas and prognosis of thrombolysis outcomes and cerebral 
angiography – for comparing the need for surgical interventions or intra-arterial 
thrombolysis (Fugate and Rabinstein 2014). Intravenous thrombolysis is not only 
effective in clinical trials, but has also become a real-world daily practice over the 
past two decades, although it increases acute therapy costs and requires stroke 
unit care. In general tPA changes our notion of ischemic stroke victims as  
hopeless cases and it actually produces economic benefits by reducing societal 
and health care costs (Johnston 2010). 
 
In summary, the pathophysiology of traumatic and ischemic injury involves a 
number of mechanisms leading to a broad spectrum of functional deficits. The 
emergency and early management phase tries to minimize secondary injury by 
stabilizing the patients’ hemodynamics, breathing capability and intracranial 
pressure, limiting secondary ischemia and hemorrhage and preventing brain 
edema. The lack of assessment approaches does not allow us to obtain accurate 
neurological information, hence limiting appropriate patients selections for 
further existing interventions with approved efficacy. Meta-analysis of 
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randomized controlled trials confirms the benefits of neurovascular or 
neuroscience unit care, but still access to them is restricted. As it has been 
reviewed above, ischemic and traumatic pathophysiological features can appear 
simultaneously in stroke and TBI patients, and their interactions mainly predict 
the clinical outcomes. The search during the last decades for a ‘‘magic bullet’’ drug 
for the treatment of stroke or TBI has totally failed. Taking into account clinical 
disease pattern, the results of pre-clinical trials and animal research, probably the 
treatment in stroke and TBI must target several coexistent pathological 
mechanisms in individual patients. 
 
2. The rodent brain as a model system for ischemic and traumatic 
injury 
Clinical unmet needs stimulate research that can facilitate our understanding of 
the pathophysiological phenomena of stroke and TBI at the molecular, single cell, 
network, and organismic levels and the development of new therapeutics to 
maintain, restore or improve the health of the patients. So far, many of the basic 
principles and mechanisms underlying pathogenesis, natural compensation and 
functional deficits have remained unclear. Many of the essential questions can not 
be addressed in humans therefore appropriate model systems are needed.  
The ideal model for stroke and TBI research should have a sufficient number of 
features that reflect the complexity of the human brain, risk factors common in 
patients and human response to injury. Presently, there are no computerized or in 
vitro models available for this purpose. Rodents, lagomorphs, cats and non-human 
primates are often used in stroke and TBI related research. Model organisms 
should not only demonstrate the ability to have injuries similar to those seen in 
humans, but should in addition be easy to breed, house and maintain as well as to 
manipulate. In this regard, rats and mice are valuable model systems since more 
than 85% of their genomes are identical to the human genome (Bejerano et al. 
2004). Furthermore, their cerebrovascular anatomies and basic physiologies show 
remarkable similarities with those of humans (Yamori et al. 1976). Nevertheless, 
during evolution the brain changes its structure to suit novel functional needs. 
Thus, the human neocortex shows a dramatic increase in surface area by means of 
a highly convoluted shape and increased number of cortical columns that 
apparently provide more powerful computational capacity (Herculano-Houzel 
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2009). In addition, there are several differences in vascular anatomy between 
rodents and humans. For example, instead of an anterior communicating artery 
rats have an azygos anterior cerebral artery formed from two proximal anterior 
cerebral arteries, they have bigger posterior communicating arteries that are 
present in both sides, and have 4-5 times more collaterals between their anterior 
and middle cerebral arteries compared to human anatomy (Lee 1995). 
Interestingly, there are some differences in cerebral vascular anatomy between 
different strains which then reflect on animal sensitivity to ischemia. For example, 
BALB/C mice are more sensitive to MCAO, since the infarct volume is significantly 
larger compare to C57BL/6 and SV-129 (Majid et al. 2000), BDF and Swiss Webster 
mice (Barone et al. 1993) since this train have a larger territory supplied by middle 
cerebral arteries. In models of global ischemia, C57BL/6 is more sensitive than 
other strains (Yang et al. 1997). As a consequence, results obtained in the model 
organism should be carefully verified. Moreover, recently it has been 
recommended to perform experiments with healthy adult male animals and then 
extent research to female and aged, overweight, diabetic, hypertensive animals 
which exhibit risk factors well-known to affect long-term outcomes (Fisher et al. 
2009). Use of an inadequate model may lead to misinterpretation of the results 
and the extrapolation from animal models to humans can be unreliable. At 
present, preclinical research aims to understand the pathogenesis and its relations 
to the primary impact and injury progression as well as identify the underlining 
mechanisms and suggest therapeutic management of stroke and TBI by means of 
in vitro and in vivo animal models. 
 
2.1. Animal models of stroke 
Starting form pioneering work by Hill and coauthors (Hill et al. 1955), a number of 
animal models have been developed to reproduce different types of stroke and 
their clinical symptoms. Each model of stroke triggers specific pathological and 
compensation mechanisms. Therefore, understanding the specific features of 
each model is essential for interpretation of the results. Here a brief introduction 
to those most relevant to the present study and frequently used in vivo stroke 
models is given. 
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2.1.1. Global ischemic models 
Global ischemia occurs when cerebral blood flow is fully blocked by cardiac arrest 
or occlusion of the four major arteries entering to the Circle of Willis (Traystman 
2003) and causes ischemic injury in vulnerable brain areas. Global ischemia can be 
complete and reversible. Complete global ischemia can be induced by euthanasia 
via 100% CO2 positive-pressure ventilation or cardiac arrest due to potassium 
chloride (KCl) injection. They rapidly decrease EEG activity (Cartner, Barlow, and 
Ness 2007) and can be used to study the onset of the injury and as a reference for 
end–point histology. There are several reversible global ischemia models, namely, 
occlusion of four-vessel (4-VO, two vertebral and two common carotid arteries), 
two vessel (2-VO, only common carotid arteries) and asphyxia cardiac arrest. They 
have been widely employed to investigate the mechanisms underlying brain 
damage after transient global ischemia. The 4-VO model was originally developed 
by Pulsinelli and Brierley (Pulsinelli and Brierley 1979) for awake rats, but it can be 
also utilized in anesthetized animals. Ten, 20, or 30 minutes of the 4-VO induce a 
severe reduction of the blood flow (<3% of control) in the neocortex, striatum, 
cerebellum and hippocampus. After reperfusion the brain experiences hyperemia 
for 5 - 15 minutes and cerebral hypoperfusion that can last for 24 hours in some 
brain structures (Pulsinelli, Levy, and Duffy 1982). Neurons have been found to be 
damaged after reperfusion in the striatum (30 minutes), hippocampus (3-6 hours) 
and posterior neocortex (1-3 days). The 4-VO has been used in many studies and 
is well validated. However, the results are highly variable in the 4-VO model due 
to its surgical difficulty and it has a success rate of about 50-75% (Traystman 
2003). 
As an alternative approach the two-vessel (2-VO) model is used. This model has 
been developed by Eklof and Siesjo (Eklof and Siesjo 1972) for characterization of 
cerebral energy state following incomplete ischemia. In the 2-VO model, both the 
ischemia and reperfusion are almost immediate, blood flow is decreased to less 
than 5% of the control in the cortex, thalamus and midbrain and is followed by 
long-term hypoperfusion (Kågström, Smith, and Siesjö 1983). Regarding our study 
it is important to mention that one week after reperfusion, neuronal damage has 
been found in the neocortex of animals exposed only to 4 minutes occlusion 
(Smith, Auer, and Siesjo 1984). In general, the 2-VO model is similar to the 4-VO, 
but requires a simpler surgical preparation. In humans global ischemia is not 
frequent, in most cases stroke affects only 4.5-14% of one hemisphere 
(Carmichael 2005). Therefore, results from global ischemia models can be directly 
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extrapolated to patients after a cardiac arrest episode or to a small proportion of 
stroke patients. However, its relevance to other clinical situations is questionable. 
 
2.1.2. Middle cerebral artery occlusion (MCAO) models 
MCAO model has been developed by Robinson and coauthors (Robinson et al. 
1975) as a model of focal ischemia that induces a decrease in blood flow by 80% in 
brain territory supplied by middle cerebral arteries. MCAO results in either a 
permanent or temporary occlusion. This model has been used extensively due to 
its relevance to human thromboembolic stroke and thrombolysis (Traystman 
2003). Several different types of MCAO models, exist such as cauterization or 
electrocoagulation via craniotomy (Tamura et al. 1981), photothrombosis 
(Markgraf et al. 1993), thromboembolic (Zhang et al. 1997) and the most widely 
used intraluminal filament technique (Longa et al. 1989). MCAO allows 
experimental access to the concept of an ischemic penumbra. In transient 
filament MCAO, the striatum experiences severe ischemia and thus it can be 
recognized as the ischemic core while the neocortex within the MCA territory is a 
region with delayed neurodegeneration after reperfusion creates an ischemic 
penumbra (Takagi et al. 1995). The infarct volume following transient filament 
MCAO is large and relevant to patients group with high mortality rate. The 
cerebral infarct can be limited to the neocortex in three-vessel occlusion version 
of MCAO (Yanamoto et al. 1998). The thromboembolic type of MCAO is induced 
by injection of thrombin that results in clot formation (Zhang et al. 1997; Orset et 
al. 2007). This model provided unique opportunity to validate thrombolytic 
treatment safety and efficacy and to study reperfusion injury in clinically relevant 
conditions. There are several concerns with MCAO models: i) subarachnoid 
hemorrhage consistently occurs and leads to decreased CBF; ii) hypothalamic 
damage is present (rarely in humans), when occlusion is 60 minutes or longer; iii) 
after surgery animals may suffer from difficulties in eating; iv) animals produce 
complex deficits that prevent specific access to function recovery (MacRae 2011). 
 
2.1.3. Rose Bengal photothrombosis model 
The photothrombosis model was developed by Watson and coauthors (Watson et 
al. 1985) to produce highly localized focal ischemia by the means of a 
photosensitized dye (Rose Bengal). When irradiated by light through the intact or 
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thinned skull or through a cranial window the dye undergoes photochemical 
reaction which leads to production of singlet oxygen that initiates damage of the 
vascular endothelium and clot formation. The size of ischemic core is highly 
reproducible and can be adjusted by dye concentration, light intensity and 
duration (Wang et al. 2010). Many ischemic pathological events seen in other 
animal models have been also observed after photothrombosis. However, as in 
the MCAO model there are several concerns with : i) free radicals not only 
stimulate platelet aggregation, but also directly damage microvasculature and 
brain parenchyma; ii) it is hard to induce controlled reperfusion, nevertheless 
spontaneous reperfusion can occur; iii) the ischemic penumbra is relatively small 
and hard to identify. 
2.1.4. Single penetrating arteriole occlusion 
Recently, model of targeted insult has been developed by Nishimura and 
coauthors (Nishimura, Schaffer, and Friedman 2006) to produce three aspects of 
stroke: i) extravasation due to BBB destruction; ii) vessel rupture to produce 
hemorrhage; iii) intravascular clot for mini-ischemic stroke. These models utilize 
nonlinear optics, namely two-photon microscopy, to induce ionization within a 
microliter volume leading to limited damage. In addition, Rose Bengal 
photosensitization with a laser light source targeted to selected microvessels on 
the cortical surface can be used to form an intravascular clot in a single vessel 
(Schaffer et al. 2006). Penetrating arterioles and veins represent a critical 
bottleneck in the flow to the cortex. Occlusion of this terminal branch of surface 
network causes a severe decrease in the blood flow of downstream capillaries and 
leads to neuronal death within the penetrating vessel territory (Nishimura et al. 
2007; Nishimura et al. 2010). It has been shown that the neurodegeneration 
following occlusion of a single penetrating arteriole in the somatosensory cortex 
leads to measurable behavioral impairments in rats (Shih et al. 2013). The mini-
strokes in rodents appear to be a highly controlled and reproducible model 
favorably relevant to TIA and silent stroke in humans. Moreover, they match 
human microinfarcts in geometry and show the ability to induce a local 
inflammatory response. 
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2.2. Animal models of TBI 
A number of models have been developed to induce brain trauma in rodents. At 
present, there are several well established models: weight-drop injury, impact 
acceleration injury, blast injury, fluid percussion injury (FPI), and cortical contusion 
injury (CCI). However, no single animal model covers the spectrum of events 
occurring in TBI patients. This section briefly introduces the most frequently used 
animal models of TBI. 
 
2.2.1. Controlled cortical impact 
A controlled cortical impact (CCI) model for focal contusions has been developed 
by Ligthall (Lighthall 1988) in ferrets and adapted for the mice (Smith et al. 1995) 
to recapitulate clinical brain injury with skull deformation and related cortical 
compression. The CCI model utilizes devises that can produce highly controlled 
time, velocity, depth of pneumatic or electromagnetic impact and deliver it to the 
brain. CCI requires accurate unilateral craniotomy lying most often between the 
bregma and lambda; much attention is paid to the dura that should remain intact 
to meet brain trauma characteristics closely. This model mimics cortical tissue 
loss, acute subdural hemorrhage, axonal injury, concussion and BBB dysfunction 
(Smith et al. 1995; Lighthall, Goshgarian, and Pinderski 1990). Neurodegeneration 
can be observed not only in the cortical region, but also in the hippocampus and 
thalamus (Hall et al. 2005). The CCI model produces persist deficits in cognitive, 
motor and sensory functions. There are two main concerns with the CCI model: 
the nature of damage in the hippocampus and assessment of the functional 
consequences (Onyszchuk et al. 2007). 
2.2.2. Fluid percussion injury 
The fluid percussion injury (FPI) model has been developed in rats by Dixon and 
coauthors (Dixon et al. 1987) to reproduce clinical features of TBI without skull 
fracture. To produce its primary impact the FPI model utilizes a pendulum to strike 
the piston of a liquid filled reservoir that result in the generation of a fluid 
pressure pulse directed to the intact dura of a test animal through a craniotomy 
(McIntosh et al. 1987). FPI models can be divided into midline, parasagittal and 
the most frequently used lateral based on the location of the craniotomy. This 
model replicates several pathophysiological consequences of human TBI such as a 
combination of focal cortical contusion, diffuse subcortical neuronal injury, 
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intracranial hemorrhage, brain swelling and progressive grey matter damage 
(Xiong, Mahmood, and Chopp 2013). There are several disadvantages in the FPI 
model: it is less controlled than CCI and a small shift in the craniotomy site is 
associated with marked differences in the outcomes; compared with other 
models, FPI has a high rate of mortality due to brainstem-compromised prolonged 
apnea (Cernak 2005). 
2.2.3. Penetrating injury 
At present, there are few stab-type (Ghirnikar, Lee, and Eng 1998) or penetrating 
ballistic-like (PBBI) (Williams et al. 2005) animal models of brain injury available to 
mimic humans open-skull or penetrating TBIs, but none of them is in routine use 
(Xiong, Mahmood, and Chopp 2013). The PBBI model utilizes a pellet accelerated 
by a modified air-rifle that hits a probe. This impact results in marked white and 
grey matter damage, brain edema, cortical spreading depression, inflammation 
and can result in sensorimotor impairment depending on the trajectory of 
penetration (Cernak et al. 2014). 
 
2.3. Modeling stroke and TBI in vitro 
In addition to animal models, there are also a variety of in vitro cell culture, acute 
and organotypic tissue preparations available to model some components of 
stroke and TBI damage. The in vitro models might be useful in the assessment of 
cellular and molecular mechanisms or for high throughput drug screenings. The 
key value of in vitro experiments is that they allow the design of more appropriate 
in vivo experiments. 
 
2.3.1. Stretch injury 
The cell stretch model has been developed by Ellis and coauthors (Ellis et al. 1995) 
in cultivated astrocytes as a simple, reproducible model of controlled strain-
related injuries. This model is extremely interesting when adapted for axonal 
dissection in the cultured primary neurons. This model not only gives a simulation 
of aspects axotomy, but also in controlled conditions allowing the study and 
manipulation of the secondary injury. 
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2.3.2. Oxygen/glucose deprivation 
Oxygen/glucose deprivation (OGD) is a commonly used in vitro model for ischemia 
in mature cortical cultures, and in acute and organotypic brain slices (Newell et al. 
1995). This model also simulates reperfusion since glucose-free and anoxic 
(oxygen is depleted with nitrogen) medium can be replaced with normal culturing 
medium. OGD typically produces both necrotic and apoptotic neuronal death. It 
has been shown that Ca2+ plays a key role in triggering cell death. 
2.3.3. Excitotoxicity 
During ischemia, ATP depletion induces neuronal depolarization that results in 
excessive synaptic release of glutamate and its accumulation in the extracellular 
space. Typically cultivated mature neurons are transiently exposed (5-10 minutes) 
to 300μM glutamate and 10μM glycine in Ca2+ - containing buffer (Choi 1985). 
Excitotoxicity as well as OGD induces neuronal death. Necrosis mainly happens in 
an acute phase due to rapid Na+ influx, osmotic imbalance and cell swelling. While 
apoptosis is delayed, it involves over-activation of NMDA-receptors, which drives 
the accumulation of Ca2+ in neurons and causes mitochondria damage. 
2.3.4. Ionomycin 
Ionomycin is the Ca2+ ionophore that permeates the plasma membrane in a 
concentration dependent manner. Increased intracellular concentration of Ca2+ 
can mimic glutamate toxicity and induce delayed degeneration by apoptosis 
(Castillo and Babson 1998). 
 
3. Role of different cell types and extracellular tissues in the rodent 
brain 
 
The brain is characterized by functional networks of different cells, including 
neurons and glia, structurally supported by the extracellular matrix. The original 
concept of brain function relies mainly on neurons wired together as electronic 
components that convey and compute activity. An increased number of 
experimental lines of evidence eventually modified our notion of the brain. Now it 
is obvious that along with neurons there are several cell types and structures 
maintaining brain function. In pathophysiological contexts, cellular and 
extracellular components of the brain are considered as the neurovascular unit 
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(NVU). Initially it was described as a “metabolic coupling” of the regional neuronal 
activity to blood flow (Harder, Zhang, and Gebremedhin 2002), presently it 
incorporates all types of neurons and astrocytes, microglia cells, oligodendrocytes, 
basal lamina, smooth muscular cells, pericytes, endothelial cells and the 
extracellular matrix (Muoio, Persson, and Sendeski 2014). Each element of the 
NVU seems to have a specific and active role in adaptations to physiological and 
pathological stimuli; nevertheless, they are coupled with one another through 
complex cell–matrix-cell interactions and communication via paracrine factors. 
The spatial organization of the NVU is still being debated, generally the cortical 
column or patch is recognized as a single NVU. Our knowledge of each component 
and their multifactorial interactions is limited (Kowiański et al. 2013), but 
understanding the NVU is crucial for understanding various diseases. 
 
 
Figure 1. Different types of brain cells. A. Pyramidal neurons (yellow) of cortical layer V 
sending their apical dendrites to cortical surface in living brain of Thy1-YFP mouse. Scale 
bar, 50μm. B. Astroglial cell (green) in neocortex of GFAP-GFP mouse. C. Astrocyte stained 
with anti-GFAP antibodies (red) contacting dendritic spines (green). D. Microglia (green) 
with ramified process probing its territory in intact cortex of CX3CR1-EGFP mouse. E. 
Perineuronal nets (green) stained with wisteria floribunda agglutinin (WFA) in cortical 
sections from adult mouse neocortex showing punctate labelling that surrounds the soma 
and proximal dendrites of neurons. B.-E. Scale bar, 10μm. 
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3.1. Neurons 
The histological studies of Theodor Schwann, Albert von Kölliker, Franz Nissl, 
Camillo Golgi, Santiago Ramón y Cajal, Auguste Forel, Alexzander Dogel’ and a 
host of successors have shown that the neuron is the structural and functional 
unit of the brain. Neurons are highly specialized electrically excitable cells with 
three distinctive compartments: soma or cell body, axons and dendrites. Neurons 
in the brain serve to transform incoming information into specific patterns of 
electrical activity. There are millions of neurons in the central nervous system and 
they can be classified based on their morphology (Uni-, Bi- or multipolar, 
anaxomic), type of released neurotransmitter (dopamine-, serotoninergic etc.), 
electrophysiological properties (fast, burst, regular, late, irregular spiking etc.) or 
function (On and Off types of visual neurons; sensory, motor or interneurons) 
(Sharpee 2014). Generally they are divided into glutamatergic excitatory and 
GABAergic inhibitory neurons, or principal and interneurons. Specific junctions 
originally called synapses by Cajal allow them to communicate with one another 
through either electrical or chemical signals (García-López, García-Marín, and 
Freire 2007). Moreover, neurons can utilize several neuropeptides (substance P, 
endorphins etc.), gaseous messengers (nitric oxide and carbon monoxide) and 
lipid mediators (e.g., arachidonic acid, endocannabinoids) to modulate ongoing 
neuronal activity and information flow. 
Assemblies of neurons can be organized into anatomical (for example the basal 
ganglio-thalamo-cortical circuit) and functional (myotatic reflex) circuits that form 
the bases for information processing. The connections in neuronal circuits exhibit 
in divergent, convergent and feedback patterns. Neurons represent the 
information in the form of action potential patterns over a given time. They 
combine and integrate information that they receive mostly from excitatory and 
partially from inhibitory sources. These signals transform either into excitatory or 
inhibitory post-synaptic potentials, which then interact at the level of single 
neurons. Integration may take various forms and originally was recognized as the 
algebraic summation of post-synaptic events. The traditional view of the neuronal 
computational properties stems from the “somatocentric” perspective where 
dendrites are recognized as passive cables. Experimentally, neuronal integration 
has been addressed by measuring somatic membrane potential and the frequency 
of action potentials initiated in the axon in response to stimuli (Jack, Noble, and 
Tsien 1975; Koch, Poggio, and Torre 1983). In this concept, a key role in the 
integration is delegated to the inhibitory inputs that act as a gatekeeper holding 
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excitation away from the soma. However, there are several lines of evidence 
showing that inhibitory interneurons have specific domains on the dendritic tree 
of the principal neurons. In addition, synaptic inputs can be nonlinearly amplified 
due to voltage-dependent conductance of the dendrites or initiation of local 
dendritic spikes. At present, the main neuronal decision - action potential 
generation has been vicarious to preceded and prepared in the dendrites 
(Sjöström et al. 2008; Branco and Häusser 2010). Remarkable advances in optical 
and genetic technologies have promoted our understanding of the nature of 
dendrites, principles of signal computation in the various forms of behavior. 
For this study the morphology of dendrites needs to be highlighted. Dendritic 
trees appear in all shapes and sizes and are highly variable not only in 
morphology, but also in the molecular composition of receptors, transporters and 
ion channels. This diversity reflects neuronal function and its connectivity 
(Migliore and Shepherd 2005). The majority of inputs from other neurons arrive at 
the dendritic spines, which are a well-studied place in the brain for the plasticity 
that underlies learning and memory. Since postsynaptic activity depends on the 
dendritic arbor properties, synaptic plasticity is indirectly affected by spine 
location in the dendritic tree. For example, inherent properties of dendrites 
determine the helical ordering of the spines in the Purkinje cells. Apparently, this 
is needed to maximize the interaction with climbing and parallel fibers as well as 
with stellate cell axons (O’Brien and Unwin 2006). Notably, dendritic morphology 
remains relatively static in the adult brain. Nevertheless, the electrical properties 
of dendritic branches (Sjöström et al. 2008), local translation (Kindler and 
Kreienkamp 2012) and vesicular trafficking (Hanus et al. 2014) can be modified 
rapidly in an activity-dependent manner suggesting that there are specific 
principles of dendritic learning. 
 
3.2. Glia 
Glial cells were first described by Rudolf Virchow, later Golgi and Cajal suggested 
that they provide structural, metabolic and homeostasis supply for neurons. 
During the last decades, several experimental observations have shown that glia 
cells undertake many other important functions in the brain (Verkhratsky and Butt 
2013). Glia cells are abundant in the central nervous system and according to 
different estimations the glia to neuron ratio is 0.35 in the neocortex of rodents. 
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Glia is a common term for non-neuronal brain cell, including astrocytes, 
oligodendrocytes, microglia, radial glia and NG2 cells. The ratio of major glia cells - 
astrocytes: oligodendrocytes: microglia - is estimated to be 10 : 5 : 1 in healthy 
adult rodent brain. 
Astrocytes are electrically silent cells that show great morphological diversity, 
classically, they have been divided into protoplasmic and fibrous subtypes. Other 
highly specialized subtypes of astrocytes have been characterized, including the 
Bergmann glia of the cerebellum and the Müller glia of the retina. Probably 
astrocytes are also diverse functionally (Matyash and Kettenmann 2010). 
Astrocytes actively participate in cell-cell communication since they are directly in 
contact with neurons, oligodendrocytes, microglia, endothelial cells and pericytes. 
These interactions suggest that they are key elements of the NVU. Astrocytes are 
connected to each other and possibly to oligodendrocytes via gap junctions 
permeable to Ca2+ and other small molecules (Parpura and Verkhratsky 2012). 
Astrocytes are tightly metabolically coupled with neurons - glucose from the 
blood is transported into the end-feet of the astrocytes via glucose GLUT-1 type 
transporters and then metabolized by glycolysis to lactate that can be transfer 
from astrocytes to neurons in an activity-dependent manner (Magistretti 2011). 
Astrocytes can affect local microcirculation as well as the properties of the BBB in 
response to increased neural activity (Takano et al. 2006). The ‘tripartite synapse’ 
concept (Araque et al. 1999) suggests that astrocytes can modulate neuronal 
activity via entrapment of synapse terminals by peripheral processes, thus 
controlling neurotransmission by active transport (Anderson and Swanson 2000). 
Microglial cells are resident monocytes that invade the brain during 
embryogenesis and serve as professional phagocytes in the brain parenchyma. 
The microglia is a highly branched type of cell, with fine peripheral processes with 
a high motility rate in their resting states (Nimmerjahn, Kirchhoff, and Helmchen 
2005). Ramified or amoeboid morphology reflects the microglial phenotype, 
phagocytic and pro-inflammatory, respectively. In contrast to astrocytes, 
microglial cells do not form durable contacts between each other and are 
territorially organized, so that each cell occupies distinct territories around 30 - 60 
μm in diameter. During brain development, they actively remove apoptotic cells 
and can be involved in synapse removal during development (Stevens et al. 2007) 
and probably can participate in synapse pruning during critical periods 
development in the postnatal brain (Paolicelli et al. 2011). In the adult brain, 
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microglial cells not only remove cell debris, they can recognize signals which tell 
them to remove parts of cells, leading to the dendritic arbor remodeling or full 
removal (Rappert et al. 2004). In addition, microglia phagocytose several 
molecules such as myelin and amyloid deposits thus contributing to the 
pathologies of Alzheimer disease and in several demyelinating disorders 
(Kettenmann et al. 2011). Moreover, microglia can react to acute injury by rapid 
processes extension towards a lesion site or extravasation from blood vessels, 
subsequent migration and injury healing (Davalos et al. 2005). 
 
 
Figure 2. A schematic representation of the neurovascular unit. Cellular components of 
the NVU: neurons, astrocytes, microglia, oligodendrocyte, pericytes and endothelial cells. 
The major compartments of the ECM in the brain: interstitial matrix and perineuronal 
nets. Concept of NVU incorporates role of each element in adaptation to physiological 
and pathological stimuli. 
Oligodendrocytes are mainly myelin-forming cells that extend many processes to 
several neurons and form multispiral cellular membrane based sheath around 
axons (Baumann and Pham-Dinh 2001). These structural properties mainly mean 
they have the same functions as oligodendrocytes. They actively participate in the 
development and regulation of axons, triggering sodium channels clustering at the 
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node of Ranvier, and thus supporting rapid action potential propagation. In the 
adult brain oligodendrocytes metabolically support axons (Morrison, Lee, and 
Rothstein 2013) and participate in the stability of neuronal circuitry by inhibiting 
axonal plasticity and growth, furthermore restricting and impairing regeneration 
after the injury. The dysfunction of oligodendrocytes may cause many 
neurodegenerative diseases like multiple sclerosis, leukodystrophies like 
Pelizaeus–Merzbacher disease and demyelinating neuropathies (Bankston, 
Mandler, and Feng 2013). 
 
3.3. Extracellular matrix 
The extracellular matrix (ECM) fills a large, approximately 10-20%, of the brain 
volume and forms a dense network of proteins and glycans (Ruoslahti 1996) that 
promote three-dimensional organization of brain cells and control local diffusion 
properties of brain parenchyma. The ECM is produced intracellularly and secreted 
almost by all brain cells. During brain development the composition of the ECM 
undergoes rapid turnover (Meyer-Puttlitz et al. 1995; Rauch 2007) leading to 
significant changes in its structure. The ECM is a source of paracrine factors that 
trigger, promote and guide cell proliferation and differentiation as well as the 
growth of peripheral processes (Bandtlow and Zimmermann 2000). When the 
active process of brain development is near to completion, the composition of the 
ECM starts to stabilize. This shifts the function of ECM towards structural 
maintenance and regulation of NVU plasticity (Dityatev and Schachner 2003). In 
the adult brain there are three types of ECM: basal lamina, interstitial matrix and 
the perineuronal nets (PNNs). 
The basal lamina is a sheet-like layer that serves as an anchor for the endothelial 
cells and as a boundary between the blood and brain parenchyma. The basal 
lamina is secreted and its composition is controlled by endothelial cells and 
astrocytes. It consists of structural elements, mainly type IV collagens and elastin, 
specialized proteins such as laminins, entactin, fibronectin and vitronectin, and of 
proteoglycans like agrin and perlecan (Yurchenco, Amenta, and Patton 2004; 
Baeten and Akassoglou 2011). Dystroglycan and integrins are the two main 
receptors/adhesion proteins that form an anchor between the basal lamina and 
the cytoskeleton of astrocytes and endothelial cell. In addition, these proteins can 
regulate intracellular signaling pathways and the expression of tight junction 
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proteins. Thus, the matrix proteins can allow cells to adapt to environmental 
changes and to modify BBB permeability (Tilling et al. 2002). 
The interstitial matrix is likely to be similar in structural organization to the 
proteoglycan component of cartilage. It contains proteoglycans, hyaluronan, 
tenascins and link proteins that together form a dense extracellular network 
(Rauch 2007). Proteoglycans consist of a core protein and negatively charged 
glycosaminoglycan (GAG) chains of repeating disaccharide units sulfated at 
various positions. Based on chemical nature of GAGs, proteoglycans are divided 
into chondroitin sulfate proteoglycans (CSPG), heparan sulfate proteoglycans, 
dermatan sulfate proteoglycans or keratan sulfate proteoglycans. CSPGs are the 
most abundant type of proteoglycan and in the brain are found by aggrecan, 
brevican, neurocan, versican, phosphacan and neuron-glial antigen 2 (Kjellén and 
Lindahl 1991). Chondroitin sulfate glycosaminoglycan chains are post-
translationally added to the protein core and consists of a varying number of 
disaccharide repeats containing N-acetylgalactosamine and glucuronic acid. In the 
developing brain chondroitin sulfate chains have been shown to bind the heparin-
binding growth factors such as HB-GAM and midkine (Rauvala 1989; Muramatsu 
2002; Deepa et al. 2002; Nandini and Sugahara 2006; Sirko et al. 2010). A 
transmembrane protein tyrosine phosphatase sigma (PTPσ) has been suggested to 
be a cellular receptor for CSPGs since its Ig-like domain binds with high affinity to 
chondroitin sulfate –GAGs (Shen et al. 2009; Fry et al. 2010). Alternatively, CSPGs 
can interact with contactin-1 or modulate integrin activation through indirect 
interaction (Mikami, Yasunaga, and Kitagawa 2009; Afshari et al. 2010). Although, 
the direct intracellular mechanism and functional consequences remain unclear, 
chondroitinase ABC (an enzyme that degrades CSPGs) treatment has been 
extensively used to demonstrate the key role of the chondroitin sulfate (CS) chains 
of the CSPGs as inhibitors of regeneration and plasticity in the adult nervous 
system (Gogolla et al. 2009; Pizzorusso et al. 2006).  
The perineuronal nets (PNNs) are composed of the same molecules as the 
interstitial matrix, but form a condensed layer of mesh-like matrix that surrounds 
a select subpopulation of neuronal cell bodies, proximal dendrites and probably 
synapses. The PNNs are often detected by lectin - wisteria floribunda agglutinin 
(WFA) that selectively labels N-acetylgalactosamines beta 1 residues of 
glycoproteins (Kwok et al. 2011). WFA-positive staining around neurons can be 
detected relatively late in the postnatal brain. Experimental results have 
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demonstrated that PNNs stabilize synapses and prevent the damage of neurons 
by free radical and buffer ions (Dityatev and Schachner 2003). Typically in the 
adult brain PNNs are associated with GABAergic parvalbumin interneurons that 
strongly contribute to functional plasticity and learning (Donato, Rompani, and 
Caroni 2013). Thus PNNs seem to be critical regulators of adult brain plasticity. 
 
4. Mitochondria 
 
Mitochondria are essential organelles in eukaryotic cells. They are involved in 
metabolism of amino acids, lipids, steroids, heme and iron-sulfur clusters, calcium 
and redox homeostasis and they act as gatekeepers of cell life and death by 
controlling apoptotic signaling pathways. The process of discovery and 
identification refers to earliest intracellular structural studies during the middle-
1800s that describe so called “granules” in the different cell types. In 1898, Carl 
Benda coined the term Fadenkorper (German) or mitochondria from the Greek 
μίτος, "thread", and χονδρίον, "granule" that arises from their presence during 
spermatogenesis (Ernster and Schatz 1981). Ideas of mitochondria structure were 
originally based on Janus Green B staining introduced by Leonor Michaelis in 
1900. However, the real beauty of mitochondrial nature was recognized in 1952 
with the pioneering electron microscopy images of mitochondria (Palade 1952; 
Sjostrand 1953). Important mitochondrial functions within the cell have been 
described by many researchers for over a century. Albert Lehninger and Eugene 
Kennedy discovered that mitochondria are the site of oxidative phosphorylation 
(OXPHOS) (Kennedy and Lehninger 1948) and Peter D. Mitchell described how the 
diffusion of hydrogen ions across membranes is related to ATP production during 
respiration in his chemiosmotic theory (Mitchell 1961). 
Unlike many other intracellular organelles, mitochondria and plant plastids are 
not synthetized de novo and are only built up from progenitors by fission. The 
endosymbiotic theory suggests that this is due to the initial capture of free-living 
aerobically respiring prokaryotic organisms by primitive cells. Mitochondria 
through their evolution as intracellular symbionts established efficient self-
regulating energy production and in delegated to their host cells transcription and 
translation of the majority of their proteins (Henze and Martin 2003). More than 
99% of mitochondria proteins (> 1000) are nuclear-encoded, possibly due to gene 
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transfer that happened during evolution, but still mitochondria have their own 
circular double-stranded genomes that contain approximately 16,600 base pairs 
and 37 tightly packed genes: 22 tRNAs, 2 rRNAs and 13 structural proteins for 
OXPHOS (Anderson et al. 1981). In fact, mitochondrial DNA (mtDNA) encodes the 
protein synthetic machinery and the remaining extremely hydrophobic 13 
subunits of the oxidative phosphorylation machinery.  
Mitochondria are double-membrane organelles and compose of the outer and 
inner mitochondrial membranes (OMM and IMM), the intermembrane space 
(IMS) and matrix. OMM has some similar features with plasmalemma, like protein 
: lipid ratio - 1:1; it contains porins, such as voltage-dependent anion channels, 
which makes it permeable to small molecules such as adenine nucleotides, 
creatine phosphate, cations, coenzyme A and a number of other metabolites as 
well as to tRNA and peptides up to 3 kDa, the diffusion of which is driven by 
concentration gradients. The OMM contains protein machinery that controls 
mitochondrial shape, their motility and signaling between the mitochondria and 
the rest of the cell. The OMM and IMM communicate with each other at contact 
sites that have been well known for a long time from electron microscopy data, 
but their functional role and molecular composition are still a subject of ongoing 
research (Reichert and Neupert 2002; Horvath et al. 2015). The IMM has some 
prokaryotic membranes properties like a high 4:1 protein:lipid ratio and 
cardiolipin enrichment (approximately 20% of the total lipids). The IMM has a 
larger surface area than the OMM due to cristae formation via infolding or 
invagination of the IMM (Mannella 2006). The electron transport chain is found in 
the IMM and it pumps protons across the IMM towards the IMS, generating an 
electrochemical gradient – the driving force for ATPase synthase that 
phosphorylates ADP to ATP. Thus, the IMM is the actual site of the OXPHOS but it 
is IMS dependent. According to high resolution electron tomography, the IMS can 
be structurally subdivided into two compartments: the peripheral IMS and the 
intracristae space. They are connected via small connections formed by cristae 
junctions (Herrmann and Riemer 2010). The mitochondrial matrix, the organelle’s 
“cytoplasm”, is a unique biochemical environment within a cell which carries out 
key metabolism reactions. It contains mtDNA, ribosomes and plenty of enzymes 
that are often organized into metabolons (Clarke and Masters 1975; Kurganov and 
Lyubarev 1988) permitting the oxidization of substrates or de novo synthesis in a 
cyclic manner (Scheffler 2001). 
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Mitochondria have a sophisticated system of membrane transporters since they 
actively exchange different ions and metabolites. Moreover, the bulk of 
mitochondrial proteins are encoded by genomic DNA and translated in the 
cytosol. The protein import is a bottleneck for adequate mitochondria function. 
Most mitochondrial proteins are synthesized as pro-proteins with 20-40 amino 
acid N-terminal targeting sequence, which contains a positively charged amino 
acid motif (Omura 1998; Habib, Neupert, and Rapaport 2007). Thus, mitochondrial 
protein import and insertion into the IMM require a mitochondria membrane 
potential that activates the channel protein and has an electrophoretic effect on 
mitochondria targeted proteins. The targeting signals allow proteins to be 
recognized by cytoplasmic molecular chaperone and directed and sorted into the 
appropriate import pathways and specific mitochondrial compartments. In the 
experimental setting, construction of hybrid protein sequences are often 
delivered into mitochondria protein of interest, for example green fluorescent 
protein. The protein sequence is fused with a mitochondrial targeting signal 
derived from the subunit 8 of human cytochrome c oxidase (COX-8) (Rizzuto et al. 
1995), rarely from E1 alpha pyruvate dehydrogenase and Mn-superoxide 
dismutase for matrix targeting or from the C-terminus of glycerol-phosphate 
dehydrogenase (Porcelli et al. 2005) for mitochondrial intermembrane space 
targeting. The import pathways of mitochondrial proteins are only partially 
understood (Endo and Yamano 2010). Nevertheless, all of them utilize ATP 
molecules and require membrane potential, therefore protein import can occur 
only in healthy mitochondria, this point is important for the present study 
(Paschen and Neupert 2001; Neupert and Herrmann 2007). Any defect in protein 
import may lead to mitochondrial disorders like deafness-dystonia syndrome 
(Binder et al. 2003), Mohr-Tranebjaerg syndrome (Bauer et al. 1999) and Jensen 
syndrome (Tranebjaerg et al. 2001). 
 
4.1. Mitochondria life cycle and metabolism 
Mitochondria regulate their own semi-autonomous “life-cycle” both in dividing 
cells and post-mitotic neurons. This involves three main stages: biogenesis, 
fission/fusion and mitophagy. The number of mitochondria varies between 
different cell types and reflects their actual metabolic consumption (Moyes and 
Hood 2003). Initial observations (Lewis and Lewis 1915; Biesele and Tobioka 1956) 
and live cell microscopy studies in the 1980s (Johnson et al. 1981; Chen 1988; 
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Farkas et al. 1989) remarkably changed our understanding of the mitochondria 
since they demonstrated the complex dynamics of this fascinating organelle. 
It is hard to identify the starting point of mitochondria biogenesis since there are 
formed from the preexisting mitochondria. In mitochondria case, biogenesis can 
be defined as division, an increase in number, that is accompanied with growth, 
an increase in size and mass (Jornayvaz and Shulman 2010). Therefore 
mitochondrial proteins as well as mtDNA should be expressed and imported 
replicated in a highly coordinated manner to facilitate the formation of two or 
more new mitochondria by division of a single progenitor. Upon cell division 
mtDNAs demonstrate mitotic segregation and approximately five mtDNAs per 
mitochondrion are randomly split. Mitochondria density within a cell is tightly 
controlled by several signaling pathways and specific transcription factors, like the 
peroxisome proliferator-activated receptor gamma coactivator-1 family of 
transcriptional coactivators (Scarpulla, Vega, and Kelly 2012). Presently, it is also 
hypothesized that there are some internal mitochondria factors that can trigger 
biogenesis (Lee and Wei 2005). The site of mitochondria biogenesis is still under 
debate. However, it is generally assumed that the biogenesis site is located near 
the cell body since protein import and mtDNA replication have been shown to 
occur perinuclearly (Davis and Clayton 1996). Moreover, it has been shown that 
healthy mitochondria in axons predominantly move anterogradely (Miller and 
Sheetz 2004). However, several experimental lines of evidence propose local 
mitochondria biogenesis. Thus for example, nuclear-encoded mitochondrial 
proteins can be translated locally in the axon (Gioio et al. 2001), and replication of 
mtDNA as well as mitochondria division can occur far away from the soma in distal 
axon (Amiri and Hollenbeck 2008). 
The key point of the mitochondrial division is fission. The protein machinery of 
mitochondria fission is well characterized and it recruits large versatile GTPases 
from dynamin superfamily members that are typically involved in membrane 
scission events (Schmid and Frolov 2011). The main regulator of fission is 
dynamin-related protein 1 (Drp1). Experimental data suggest that fission starts 
with accumulation of mitochondrial fission protein 1 on the OMM. Next, it recruits 
mitochondrial division protein 1 from the cytosol. When this protein becomes 
membrane-associated, it nucleates the assembly of Drp1–GTP oligomers that 
form spirals around mitochondria. Finally, GTP hydrolysis of the Drp1–GTP 
oligomers severs both the OMM and IMM in the classical manner known for 
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dynamins (Westermann 2010; van der Bliek, Shen, and Kawajiri 2013). It has been 
demonstrated that Dpr1 self-assembles can be initiated at the positions where the 
endoplasmic reticulum (ER) contact mitochondria, suggesting an active role for 
the ER in fission (Friedman et al. 2011). The nature of IMM division during 
mitochondria fission at present has been only surmised from electron microscopy 
data and the protein machinery that mediates IMM separation has not been 
elucidated. 
Two mitochondria can join to form a single mitochondrion: this process is called 
fusion. Although membrane fusion is one of the basic processes that happens in 
cells, the protein machinery realizing it is quite diverse (Martens and McMahon 
2008). In the case of mitochondria, simultaneous fusion of the OMM and IMM is 
required. Several lines of evidence suggest that mitofusins 1, 2 - membrane-
anchored dynamin family GTPases are responsible for fusion of the OMM, while 
optic atrophy factor 1 (OPA1) is required for IMM fusion (Westermann 2010; van 
der Bliek, Shen, and Kawajiri 2013). Following fusion, mitochondria solutes, 
metabolites and proteins are redistributed in the matrix leading to optimization of 
the mitochondrion’s bioenergetics. Furthermore, fusion can be recognized as a 
protective mechanism that allows the repair of damaged mitochondria by 
intermixing their components with healthy mitochondria allowing their damaged 
proteins to be proteolysed and mutant mtDNA repaired. 
Mitochondria have a limited lifespan, and it is about 24-30 days in rat brain and 9-
10 days in the liver (Gross and Rabinowitz 1969; Menzies and Gold 1971). On one 
hand mitochondria have essential metabolic function, on the other their 
dysfunction determines cell death (de Grey 2005; Green and Reed 1998). 
Damaged mitochondria should be quickly recognized and removed to avoid 
harmful consequences. Mitophagy mediates the selective removal of damaged 
mitochondria, moreover it assures the steady-state turnover of mitochondria 
(Kim, Rodriguez-Enriquez, and Lemasters 2007; Youle and Narendra 2011). 
Typically, elongated mitochondria undergo asymmetric fragmentation into 
healthy tubules and small depolarized globules which are suitable for 
encapsulation. Then, PTEN induced putative kinase 1 (PINK1) recruits cytoplasmic 
E3 ubiquitin ligase – parkin that actively ubiquitinylates mitochondrial proteins. 
These trigger mitochondria engulfment by autophagosomes and further fusion 
with lysosomes for proteolytic degradation (Eiyama and Okamoto 2015). The site 
of the mitophagy like the biogenesis is still under debate. Some experimental 
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results suggest that the degradation occurs near the cell soma where the majority 
of lysosomes are located since depolarized mitochondria in axons predominantly 
move retrogradely (Miller and Sheetz 2004) and autophago-lysosmes maturate 
during this translocation (Maday, Wallace, and Holzbaur 2012; Sheng 2014). 
However, other experiments suggest that mitophagy happens locally due to the 
arrest of motor proteins (Wang et al. 2011) or even through local transmitophagy, 
where clustered mitochondria in axons are expelled to neighboring astrocytes and 
then degraded in lysosomes (Davis et al. 2014). 
During the interplay between biogenesis and mitophagy, mitochondria perform 
well-studied metabolic reactions, including oxidative phosphorylation, Krebs 
(tricarboxylic acid) cycle, beta-oxidation of fatty acids, heme synthesis and 
gluconeogenesis. It has been shown that mitochondria function can be modulated 
through calcium accumulation (Szabadkai and Duchen 2008). Calcium can increase 
ATP production by enhancing pyruvate uptake and the activity of the Krebs cycle 
enzymes (McCormack, Halestrap, and Denton 1990) as well as by direct effect on 
ATP synthase activity (Jouaville et al. 1999). On the other hand, mitochondria can 
serve as cytosolic calcium sinks since they have a huge capacity to accumulate 
calcium (Dhalla 1969). Under resting conditions cytosolic calcium concentration is 
remarkably low (50 nM) due to activity of calcium binding proteins and vigorous 
Ca2+ efflux into the extracellular space and intracellular stores (Ghosh and 
Greenberg 1995; Gilabert 2012). Mitochondria can take up to 1-5 μM of calcium 
into the matrix and are able to withhold a 100-fold gradient across the IMM using 
a mitochondrial membrane potential dependent mechanism (Nicholls and 
Chalmers 2004). Mitochondria spatiotemporally regulate global and local cytosolic 
calcium concentration (Tinel et al. 1999). Therefore, they tune one of the key 
intracellular signaling pathways, this is highly significant for all cells and 
particularly for neurons since calcium concentration regulates gene expression, 
controlling vesicle secretion and electrical activity (Brini et al. 2014). Up to now, 
the specific molecular nature of the mitochondrial calcium uptake remains 
unknown, although several routes have been proposed (Santo-Domingo and 
Demaurex 2010; Olson, Chalmers, and McCarron 2012). Calcium can enter into 
mitochondrial through voltage-dependent anion-selective channels in the OMM 
and in the IMM through Ca2+ uniporter (MCU) (Kirichok, Krapivinsky, and Clapham 
2004), high-affinity Ca2+/H+ exchangers (LetM1) (Zotova et al. 2010) or uncoupling 
proteins (UCP2 and 3) (Kapùs et al. 1991; Gunter et al. 2000). In addition, 
mitochondrial ryanodine receptor type 1 has been speculated to participate in 
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calcium uptake, although this channel is not found in the IMM (Salnikov et al. 
2009). It has also been suggested that several pathways of calcium uptake co-exist 
in the mitochondria to deal with the different concentrations during cytosolic 
calcium elevations (Olson, Chalmers, and McCarron 2012; Graier, Frieden, and 
Malli 2007). In the mitochondria matrix calcium is buffered in a pH dependent 
manner by the formation of insoluble xCa2+-xPO4x--xOH– complexes (Nicholls and 
Chalmers 2004). The major route for calcium extrusion into the surroundings from 
mitochondria is through an xNa+/Ca2+ exchanger that is coupled to the H+ gradient 
across the IMM through a Na+/H+ exchanger. At present, it is generally accepted 
that calcium mediates bidirectional signaling aimed to tune mitochondria 
metabolic performance accordingly to actual needs (Szabadkai and Duchen 2008).  
 
4.2. Mitochondria morphology, dynamics and trafficking 
Mitochondria display a very complex architectural organization that is dynamic 
and varies highly between cell types and within an individual cell as well as under 
different physiological and environmental conditions. Historically, mitochondria 
morphology has been studied with conventional transmission electron microscopy 
that generates two-dimensional (2D) image from a single thin section of an object 
with a complicated geometry. This approach is imprinted in our mind and we 
usually think of mitochondria as static organelles with a stable morphology. In 
addition, it leads to misinterpretation of actual mitochondria morphology since in 
most cases it is impossible to accurately trace a single mitochondrion. In the last 
decades, serial block-face scanning electron microscopy and electron tomography 
have permitted 3D reconstruction of mitochondria (Perkins et al. 1997; Mannella 
2006). Recently, cryo-electron tomography has made it possible to overcome 
artifacts induced by fixation, dehydration and staining (Costello 2006). 
Furthermore, live cell imaging and super-resolution optical techniques have 
increased our comprehension of mitochondrial complexity and dynamic behavior. 
Mitochondria at can elongate or shorten in their resting state. Morphological 
changes in mitochondria are dynamically controlled by constantly ongoing fusion 
and fission. In a single cell mitochondria can be presented both as small globules 
and short tubes that are functionally independent and electrically isolated from 
each other and as large interconnected filamentous networks (Park et al. 2001; 
Collins et al. 2002). It has been suggested that large mitochondrial networks are 
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beneficial for oxidative phosphorylation and calcium buffering (Skulachev 2001; 
De Giorgi, Lartigue, and Ichas 2000). The key members of the fusion/fission 
machinery have been briefly described above. Several protein modifications like 
phosphorylation, sumoylation, s-nitrosylation, O-glycosylation and ubiquitylation 
have been proposed to regulate the proteins of the fusion/fission machinery, thus 
affecting mitochondria morphology (Knott et al. 2008). Disruption of this 
machinery leads to neurodegenerative disease like Charcot-Marie-Tooth subtype 
2A peripheral neuropathy (Sajic 2014), optic atrophy (Alavi and Fuhrmann 2013) 
and strongly contributes to amyotrophic lateral sclerosis (Bruijn, Miller, and 
Cleveland 2004), Huntington (Costa and Scorrano 2012), Parkinson’s (Scarffe et al. 
2014) and Alzheimer's diseases (Readnower, Sauerbeck, and Sullivan 2011; Schon 
and Przedborski 2011; Lin and Beal 2006). The fission/fusion equilibrium directly 
reflects current metabolic and homeostatic needs. Unbalanced fission leads to 
mitochondria fragmentation whereas disturbed fusion results in mitochondria 
elongation (Karbowski and Youle 2003). 
There is a growing number of indications suggesting a bidirectional relationship 
between mitochondrial morphology and function (Picard et al. 2013; Wang, and 
Yoon 2015). For example, OXPHOS inhibition by rotenone (Frank et al. 2012), 
antimycin A (Barsoum et al. 2006), 3-nitropropionic acid (Liot et al. 2009) and 
chemical uncouplers (Ishihara et al. 2003) induce mitochondrial depolarization 
that triggers the cleavage of OPA1, resulting in disrupted mitochondrial 
morphology (Ishihara et al. 2006). Furthermore, mitochondria can elongate in 
response to starvation or rapamycin-induced autophagy (Gomes, Di Benedetto, 
and Scorrano 2011; Rambold et al. 2011). Thus, mitochondrial morphology 
indicates the energetic states of cells (Lyamzaev et al. 2004; Benard et al. 2007). 
On the other hand, mitochondria alterations introduced in cells by knock-down or 
overexpression of fission/fusion proteins affect key mitochondrial functions. Cells 
lacking mitofusin 2 have reduced mitochondria membrane potential, lower 
oxygen consumption and less active OXPHOS. In contrast, overexpression of the 
same protein significantly improves mitochondrial metabolism (Pich et al. 2005). 
Knock-down of OPA1 or Drp1 have a similar mitochondrial phenotype as in 
mitofusin 2 with a lower mitochondrial membrane potential and decreased 
respiration rates, although its overexpression does not affect mitochondria (Chen, 
Chomyn, and Chan 2005). Blockage of fission leads to decreased mitophagy and 
results in accumulation of damaged mitochondria that start to overproduce 
reactive oxygen species and  induce oxidative stress (Parone et al. 2008). Notably, 
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when fission and fusion are blocked simultaneously mitochondrial morphology 
remains intact. However, reduced respiration can still be observed (Okamoto and 
Shaw 2005). Different mitochondrial morphologies and the ability of mitochondria 
to rapidly alter their morphologies have generated much speculation (Friedman 
and Nunnari 2014). When comparing experimental results from mitochondrial 
experiments, it is extremely important to control experimental conditions and be 
careful in the extrapolation of data from yeast to mammalian cultivated cells and 
further to in vivo situations. 
The cytosolic localization of mitochondria is not random; they move where higher 
ATP amounts are required or where cytosolic Ca2+ elevations need to be 
regulated. Mitochondria move rapidly from one cellular region to another in a 
complex surveillance-like fashion, and their movement can be accompanied with 
fission/fusion events (Twig et al. 2010). Mitochondrial motility is mediated by 
motor proteins stepping along cytoskeletal elements (Morris and Hollenbeck 
1995). Three large super-families of molecular motors have been identified: 
kinesins – for anterograde movement toward the (+)-end of microtubules; dynein 
- for retrograde toward (−)-end; and myosins – for movement along actin. 
Mitochondrial anterograde transport mostly relies upon kinesin superfamily 
protein 5 (KIF5) motors that attach through the Milton adaptor protein and the 
Miro OMM receptor in Drosophila (Sheng 2014). In mammals, there are Trak1 and 
Trak2, instead of Milton, that can mediate both KIF5- and dynein-driving bi-
directional transport of mitochondria (van Spronsen et al. 2013). In addition, there 
are Miro1 and Miro 2; each containing GTPase and Ca2+-binding (EF-hands) motifs. 
In parallel to the Miro/Milton complex, other proteins have been shown to 
associate with kinesins and mitochondria: syntabulin, FEZ1 and RANBP2 (Lovas 
and Wang 2013).While mitochondria bind to KIFs via adaptors, for dynein it is not 
entirely clear which (if any) adaptors are involved. Although mitochondria are able 
to travel along actin, little is known about actin motors or their mitochondrial 
adaptors. The exact mechanism of the transition between immobility and 
transport remains unknown. Presently, it has been proposed that Miro at sites of 
high intracellular calcium promotes mitochondrial detachment from microtubules 
(Da Silva et al. 2014; Sheng 2014; Lovas and Wang 2013). 
Mitochondria morphology has particular features in neurons since they are post 
mitotic cells that have highly distinctive compartments. Mitochondria in neurons 
are involved in the biosynthesis of neurotransmitters, regulation of intracellular 
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Ca2+ signaling, acting as a sink and storage of Ca2+, and they are important for 
synaptic communication and neuronal plasticity (Chan 2006; Mattson, 
Gleichmann, and Cheng 2008). In dendrites and axons mitochondria are usually 
orientated longitudinally and may be several microns long. Pioneer electron 
microscopy studies described mitochondria with “extraordinary length” - up to 9 
μm in the dendrites of adult cat neocortex (Pappas and Purpura 1961). In 
contrast, mitochondria in axons are usually much shorter and non-significantly 
differ from somatic mitochondria in length. Notably, mitochondria form really 
long filaments as it has been demonstrated in cultivated fibroblasts. Their lengths 
can be there as long as 50 μm (Amchenkova et al. 1988). Serial electron 
microscopy of hippocampal slices from adult rats and ground squirrels and 
subsequent 3D reconstructions of dendrites and mitochondria revealed that 
mitochondria are present in filamentous forms of at least 36 μm in length (Popov 
et al. 2005). In contrast to dendritic processes, the mitochondrial population of 
the axonal processes in the same hippocampal regions have been shown to exist 
only in the form of discrete bodies, no longer than 3 μm in length (Popov et al. 
2005). From what have been seen in vitro primary cultivated neurons, 
mitochondria in dendrites are more generally believed to be present only as 
discrete bodies. The dynamic nature of mitochondria and the remarkable 
complexity of dendrites and axons have highlighted several fundamental 
questions and opened up a new era of mitochondria research in neuroscience. 
Where the focus is no longer kept on metabolism and homeostasis per se, but on 
mitochondria as part of an integrated subcellular system. Adaptation and transfer 
of our knowledge regarding mitochondria to the in vivo situation is an ongoing 
mission in many laboratories. 
 
5. Mechanisms of ischemic and traumatic brain injury 
 
The brain is a highly metabolically active organ which requires a constant supply 
of oxygen and glucose to maintain its function. Early observations of the 
mechanisms of ischemic and traumatic brain injury focused mainly on biochemical 
and physiological changes. They revealed that primary impact accompanied with 
circulation interruption results in: i) inhibition of the electron transport chain in 
mitochondria and decreased cell level of ATP (Reichelt 1968; Broniszewska-Ardelt 
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and Jongkind 1971; Yatsu, Lee, and Liao 1975; Siesjö and Ljunggren 1973); ii) 
acidosis due to accumulation of lactate and markedly decreased intra- and 
extracellular pH (Ljunggren, Norberg, and Siesjö 1974; Siesjö 1988; Smith, von 
Hanwehr, and Siesjö 1986); iii) losses of intracellular potassium and a large influx 
of calcium into cells (Prenen et al. 1988; Dienel 1984; Hossmann and Grosse 
Ophoff 1986; Yanagihara and McCall 1982; Hansen 1985); iv) release of glutamate 
and excitotoxicity (Choi 1985; Hahn, Aizenman, and Lipton 1988; Meldrum and 
Garthwaite 1990; Olney and Sharpe 1969; Novelli et al. 1988; Palmer et al. 1993; 
Vespa et al. 1998; Faden et al. 1989); v) increased free fatty acids and arachidonic 
acid, activated lipid peroxidation and free radical production (Yoshida et al. 1984; 
Flamm et al. 1978; Bazán and Rodríguez de Turco 1980; Majewska, Strosznajder, 
and Lazarewicz 1978; Kuwashima et al. 1978; Bazán 1976); and vi) cytokine 
synthesis and inflammation (Garcia and Kamijyo 1974; Yamasaki et al. 1995; 
Minami et al. 1992). Moreover, it has been demonstrated that initial pathogenesis 
and non-selective loss of all cell types happens in the core or focal tissue and can 
spread further and increase damage to penumbral or perifocal tissue (Memezawa 
et al. 1992; Hossmann 1994; Astrup, Siesjö, and Symon 1981). Metabolic stress 
and ionic perturbations are generally accepted major contributors damage seen in 
cerebral ischemia and brain trauma. During the last decade, it has become clear 
that pathogenesis is far more complex than has been previously suggested. 
Subsequent research has shown the action and interaction of many factors 
contributing to loss of cellular integrity and tissue destruction. Below the specific 
aspects of pathophysiological events which occur following ischemic and 
traumatic brain injury are described. 
 
5.1. Cellular and microenvironment events in infarct of ischemia and brain 
trauma 
Studies in vitro and in laboratory animals allow us to identify the key reasons for 
energy production failure. In ischemic core or trauma foci, interstitial рО2 and 
glucose metabolic rates are found to be near zero leading to ATP and 
phosphocreatine depletion (Folbergrová et al. 1992). Tissue anoxia or severe 
hypoxia (15–10 mm Hg pO2) is the main initial consequence of ischemic and 
traumatic brain injury (Rose, Neill, and Hemphill 2006). These conditions 
immediately affect neuronal functioning since the majority of ATP is consumed by 
plasma membrane ATPases which ensure ionic gradients during resting 
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membrane potential and action potential prorogation (Erecinska and Silver 1989). 
Typically, the mammalian brain subjected to global or focal injury demonstrates 
rapid suppression of EEG activity within 10–20 seconds of onset (Hossmann and 
Olsson 1970; Siesjö 1981; Murphy et al. 2008). Probably this happens as a result of 
energy failure due to anoxia and hypoglycemia that immediately leads to 
dissipation of cellular ionic gradients (Hansen 1984; Jiang, Xia, and Haddad 1992; 
Zandt et al. 2013). 
The initial pathophysiological process following ischemic and traumatic brain 
injury is often called anoxic depolarization. It includes energy failure, loss of 
electrolyte balance, neuron and glia depolarization and water influx. The 
parenchymal concentration of ATP decreases dramatically in ischemic core or 
trauma foci during the first 5 min of injury (Folbergrová et al. 1992) and then 
during the initial hours stabilizes at 10-20% of the baseline level (Welsh, Marcy, 
and Sims 1991; Folbergrová et al. 1995; Katsura et al. 1993). Creatine kinase can 
restore ATP levels from phosphocreatine and ADP. However, it is not efficient and 
phosphocreatine concentration shows a similar decrease as ATP. Furthermore, 
glucose that reaches the core or the focal tissue undergoes glycolysis with the 
production of ATP, thus supporting membrane pumps for a longer time. However, 
this is accompanied by an increased production of NADH and 10-fold 
accumulation of lactate causing intra- and extracellular acidosis to approximately 
pH 6.6 (von Hanwehr, Smith, and Siesjö 1986; Nedergaard et al. 1991). Acidosis 
reduces ion fluxes through cellular membrane channels (Moody 1984), thus it can 
be classed as one of the adaptive mechanisms that reduces energy requirement. 
Cells can tolerate low pH only for several minutes (Hoxworth et al. 1999); 
prolonged acidosis disturbs cell function and can trigger edema (Yao and Haddad 
2004). 
The early events are now well-studied in acute hippocampal and cortical slices 
where anoxic depolarization is mimicked by induction of oxygen/glucose 
deprivation or ouabain treatment, which inhibits Na+/K+-ATPase. Initially, neurons 
subjected to OGD demonstrate adaptive compensation through increased 
membrane permeability to potassium ions and suppression of voltage-dependent 
Na+ and Ca2+-channels (Tanaka et al. 1997). The cells have increased extracellular 
concentrations of potassium hyperpolarized membranes that can be detected in 
electrophysiological recordings as a substantial drop of membrane resistance, 
reduced cell excitability and firing (Fujiwara et al. 1987; Krnjević and Leblond 
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1989; Yamamoto, Tanaka, and Higashi 1997). Sooner or later, the activity of 
Na+/K+-ATPase decreases in affected cells and causes loss of ionic gradients across 
the plasma membrane (Hansen 1984). At this time, an electrochemical gradient 
drives substantial sodium, calcium and chloride ion influx into the cell resulting in 
gradual depolarization followed by rapid major depolarization that approaches 0 
mV (Rader and Lanthorn 1989; Silver and Erecińska 1990; Jiang, Agulian, and 
Haddad 1992). Very likely, ion influx occurs through several pathways. 
Depolarization reverses the operational direction of the Na+/Ca2+ exchanger since 
it is driven by the electrochemical Na+ gradient. This together with failure of ATP-
dependent Ca2+ extrusion causes massive Ca2+ uptake resulting in micromolar 
intracellular levels of this ion (Xie et al. 1995; Stys and Lopachin 1997). In addition, 
the sodium–potassium–chloride co-transporter 1 (NKCC1) becomes deregulated 
and contributes to excessive Na+ accumulation (Sheldon et al. 2004). Moreover, 
the potassium–chloride co-transporter 2 (KCC2) cannot effectively extrude 
chloride; thus, its intracellular concentration increases leading to deterioration in 
the strength of GABAergic hyperpolarization through the GABAA receptor (Rivera 
et al. 1999; Kahle et al. 2008). These change neuronal excitability and the 
excitatory/inhibitory balance. As a result, anoxic injury leads to extracellular 
accumulation of glutamate, GABA, aspartate, alanine and ammonia (Katayama et 
al. 1991; Pocock and Nicholls 1998). Increase of extracellular glutamate 
concentration to toxic levels has been found in human beings, especially after 
focal parenchymal contusions (up to 50-fold) (Bullock et al. 1998), and in rats 
during transient ischemia (Benveniste et al. 1984). The following mechanisms of 
glutamate release in ischemic and traumatic brain injury have been suggested: i) 
opening of potassium-induced voltage-gated ion channels resulting in intracellular 
Ca2+ elevation (Drejer et al. 1985) or ii) Ca2+ release from intracellular stores 
(Katchman and Hershkowitz 1993) that induces massive exocytosis of glutamate 
vesicles; iii) the reversed operation of glutamate transporters (Rossi, Oshima, and 
Attwell 2000). 
Presently, it is generally appreciated that extracellular glutamate accumulation 
and Ca2+ overload are essential pathophysiological mechanisms of ischemic and 
traumatic brain injury mediating a significant portion of the cell damage (Lipton 
1999; Andriessen, Jacobs, and Vos 2010; Kostandy 2012). Glutamate is the key 
excitatory neurotransmitter in the mammalian brain that can activate several 
ionotropic (NMDA, AMPA, kainate) and metabotropic glutamate (mGluR1-8) 
receptors with specific intracellular consequences in neurons and glia cells. The 
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neurotoxin property of glutamate was first shown several decades ago (Lucas and 
Newhouse 1957; Rothman 1985; Olney and Sharpe 1969). These initial 
observations eventually formed the basis for the “excitotoxicity hypothesis” 
where glutamate mediates neuronal damage through neuronal excitation 
(Rothman and Olney 1986). Subsequent in vitro studies have suggested a dose – 
response relationship; high concentrations immediately cause necrosis whereas 
low concentrations induce delayed apoptosis (Choi 1985). Furthermore, it has 
been shown that in hypoxia and hypoglycemic conditions neurons become more 
sensitive to lower concentrations of glutamate (Kimura, Katayama, and Nishizawa 
1999). The excitotoxicity hypothesis has been strongly supported by preclinical 
evaluation of the glutamate receptor antagonists that demonstrated strong 
neuroprotective effect and significant reduction of the infarct size in animal 
models of stroke and TBI (Gill, Foster, and Woodruff 1987; Myseros and Bullock 
1995; Rao et al. 2001; Marklund et al. 2006; Durukan and Tatlisumak 2007). 
Unfortunately, clinical trials have failed to demonstrate any effectiveness of these 
agents (Muir and Lees 1995; Hoyte et al. 2004; O’Collins et al. 2006; Chacon et al. 
2008). 
In the ischemic core or trauma foci, the process of glutamate re-uptake is found to 
be suppressed (Camacho and Massieu 2006). The extracellular concentration of 
glutamate is strictly regulated by high affinity ATP-dependent sodium-
cotransports (Storck et al. 1992; Danbolt, Storm-Mathisen, and Kanner 1992): 
glutamate-aspartate transporter and glutamate transporter 1, can both be located 
in neurons as well as in astrocytes. Under conditions of limited energy production 
these transporters can additionally mediate the release of glutamate since they 
follow Na+ gradient (Nicholls and Attwell 1990; Rossi, Oshima, and Attwell 2000). 
Prolonged accumulation of glutamate in the synaptic cleft and subsequent 
spillover to extracellular spaces lead to hyperactivation of glutamate receptors 
and sustained depolarization of plasma membranes removes the voltage-
dependent Mg2+ block of NMDA receptors (Mayer, Westbrook, and Guthrie 1984; 
MacDonald, Xiong, and Jackson 2006). It is believed that this ligand-gated cation 
channel is a major route for excessive Ca2+ influx in ischemic and traumatic brain 
injury (Salinska, Pluta, and Lazarewicz 1989; Faden et al. 1989; Monyer et al. 
1992). 
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Figure 3. Key pathophysiological events triggered by stroke and TBI. Specific and common 
(green) features of ischemic (red) and traumatic brain (blue) injury presented during 
immediate, acute, sub-acute and chronic phases of injury progression. (Modified from 
(Bramlett and Dietrich 2004)). 
The rise in intracellular Ca2+ seems to play a major role in linking excitotoxicity 
with cell death (Choi 1985; Isaev et al. 2008). When Ca2+ enters neurons through 
NMDA receptors, it can directly activate neuronal nitric oxide synthase which 
starts to produce nitric oxide (Sattler et al. 1999). In addition, it also triggers the 
activity of membrane phospholipase, protein kinases and cyclooxygenase which 
contribute to the production of free radicals (Lafon-Cazal et al. 1993) and 
membrane damage (Won, Kim, and Gwag 2002). Moreover, intracellular Ca2+ can 
be deregulated further by its release from intracellular stores induced via 
metabotropic glutamate receptor activation (Opitz and Reymann 1991) or Ca2+-
induced Ca2+ release (Llano, DiPolo, and Marty 1994). Delayed calcium 
deregulation has been suggested to amplify neuronal death in glutamate-induced 
excitotoxicity (Alano et al. 2002; Horn et al. 2002; Khodorov 2004; Abramov and 
Duchen 2008). Interestingly, neurons have differences in glutamate receptor 
expression and in Ca2+ homeostasis regulation which results in specific patterns of 
Ca2+ elevation during and following ischemic and traumatic brain injury leading to 
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mosaic and selective regional vulnerability (Kirino and Sano 1984; Mitani et al. 
1994; Schmidt-Kastner and Freund 1991). It is clear that there are additional 
pathways by which Ca2+ overload may occur in ischemic and traumatized neurons 
(Zündorf and Reiser 2011). High cytotoxic Ca2+ levels have been suggested to 
overstimulate catabolic enzymes, calpains and other proteases (Yokota et al. 
2003; Roberts-Lewis et al. 1994), calcineurins, and endonucleases causing 
cytoskeletal breakdown (Waxman et al. 1993), DNA fragmentation (Charriaut-
Marlangue et al. 1995), mitochondrial (Starkov, Chinopoulos, and Fiskum 2004; 
Chinopoulos and Adam-Vizi 2006) and endoplasmic reticulum dysfunction 
(Paschen 1996; Bodalia, Li, and Jackson 2013) and finally cell death. Although 
numerous events have been identified and characterized at the molecular and 
cellular levels, a way to stabilize brain Ca2+ homeostasis has not yet been found. 
Further elucidation of interactions of pathological processes in different neural 
and glial cell types may allow Ca2+ signaling to be targeted. 
 
5.2. Cellular and microenvironment events in penumbral and perifocal tissue 
Pathology is less drastic in the penumbral and perifocal tissue, although it still 
leads to infarct. The blood supply to the region is reduced but constant (Dunn et 
al. 2001), thus energy metabolism is less severely altered - levels of ATP and 
phosphocreatine are reduced to approximately 50–70% of baseline level. 
Moreover, PET and autoradiography studies have demonstrated that in the 
penumbral and perifocal tissue blood flow is lowered, but constant interstitial рО2 
is maintained (Liu et al. 2004), whereas glucose metabolism during the first hours 
is significantly increased (Nedergaard, Jakobsen, and Diemer 1988; Back, Zhao, 
and Ginsberg 1995; Belayev et al. 1997; Kuge et al. 2001). However, it drops to the 
same level as in the core after 3.5 hours (Yao et al. 1995). Lactate accumulation 
has been detected within the penumbra. It is several times lower than in the core 
regions (Folbergrová et al. 1995) indicating mitochondria dysfunction. The total 
glutamate content in the tissue is unchanged at the unset of injury, further it is a 
gradually elevated and reaches a maximum in one day (Stoffel et al. 2002; Bonova 
et al. 2013). Notably, there are normal ionic gradients and no signs of anoxic 
depolarization, therefore there is no EEG in this region (Strong, Venables, and 
Gibson 1983; Zhang et al. 2013). Multiple mechanisms have been identified over 
the past few decades that are responsible for triggering and continuously 
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stimulating molecular and cellular events leading to injury spreading from the 
core to the penumbra (Moskowitz, Lo, and Iadecola 2010). 
Initial excitotoxic events, mainly associated with massive release of glutamate and 
ionic imbalance, have negative impact at the tissue level further promoting 
ischemic and traumatic injury. During the hours and days following the injury 
onset repeated vasogenic, cytotoxic edema and anoxic depolarization-like events 
occur spontaneously in experimental focal cerebral ischemia or TBI, as well as in 
various human brain injuries (Unterberg et al. 2004; Simard et al. 2007; Hartings 
et al. 2009; Lauritzen et al. 2011; Z. Bere et al. 2014). 
Originally a wave of electrical silence lasting several minutes was described 
following interruption of the cerebral circulation (Leao 1947). Initiated from the 
border of the ischemic core or trauma foci (Hartings et al. 2003) anoxic 
depolarization-like events termed peri-infarct depolarizations (PIDs) propagate 
through the surrounding brain area that is partially metabolically and functionally 
compromised (Nedergaard and Hansen 1993; Mies, Iijima, and Hossmann 1993; 
Fabricius et al. 2006; Oliveira-Ferreira et al. 2010). PIDs are characterized by 
potential recordings as cortical direct current shifts of around 20 mV propagating 
slowly at the speed of 3–5 mm/min associated with massive disturbance of 
membrane ion homeostasis. PIDs may also spread out into healthy brain tissue, 
where they are recognized as cortical spreading depression (CSD). As described 
above, anoxic depolarization results in irreversible damage since the affected cells 
are metabolically arrested and cannot repolarize, leading to cell death within 
minutes. In cases of cortical spreading depressions, abrupt and deep 
depolarization is innocuous and can even happen as migraine aura without 
metabolic compromise (Dreier 2011). Presently, PIDs are proposed to promote 
cell damage by diminishing available energy (Heiss 2012). 
PIDs are suggested to be triggered by high levels of extracellular glutamate and 
more favorably by high potassium. The slow rate of PIDs propagation indicates 
that they are probably mediated by chemical diffusion; the underlying mechanism 
and the diffusion pathway are still under debate (Pietrobon and Moskowitz 2014). 
PIDs induce transient changes in regional cerebral blood flow ranging from 
transient hyperemia to transient hypoperfusion (Chuquet, Hollender, and 
Nimchinsky 2007; Farkas et al. 2011; Lückl et al. 2012; Bere et al. 2014). During the 
depolarization wave propagation the metabolic rate of the penumbral and 
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perifocal tissue markedly increases, most likely due to the considerably enhanced 
energy demands of the activated ion exchange pumps (Somjen 2001). A mismatch 
between metabolic needs and reduced glucose and oxygen supply leads to 
phenomenon termed spreading ischemia (Dreier 2011). As it has been reported in 
animals models of stroke and TBI, 3–4 hours following the onset of injury PIDs 
promote acute injury to the neuronal circuitry (Risher et al. 2010) and expands the 
size of the infarct (Takano et al. 1996; Hartings et al. 2003; Hartings et al. 2011). 
Inhibition of initiation and propagation of PIDs with AMPA and NMDA receptor 
antagonists are found to be protective in vitro and in the animal models (Sakowitz 
et al. 2009; Eikermann-Haerter et al. 2015), but still cannot be addressed in 
humans. 
Another pathological consequence at the tissue level is development of cerebral 
edema. Brain swelling following ischemic and traumatic injury can mainly occur 
with water influx from the vasculature, whereas cytotoxic edema represents a 
shift of water from the extracellular to intracellular compartments that can be 
accompanied by shrinkage of the extracellular space. It is generally accepted that 
cytotoxic edema is induced by an increase in the intracellular concentration of 
osmotic active solutes (especially Na+), failure of the active ion-pumps, mainly 
Na+/K+-ATPase and extracellular hypoosmolality (Kimelberg 1995; Unterberg et al. 
2004). Although all neuronal and glial cell types swell to maintain osmotic 
neutrality, the astrocytes contribute most to brain swelling due to unique 
composition of their plasma membrane transporters (Saadoun and Papadopoulos 
2010). In astrocytes water transport is facilitated through specific water channels, 
aquaporins, which allow osmotic gradient dependent bidirectional water flux 
(Agre 2006). Aquaporin 4 (AQP4) is the most abundant water channel in the brain 
(Nagelhus and Ottersen 2013) and is mainly located on astrocytic endfeet 
surrounding blood capillaries (Papadopoulos and Verkman 2013). Interestingly, 
AQP4 is often found to be co-localized with Kir4.1 K+-channels suggesting co-
regulation of water and K+ homeostasis. AQP4 has been shown to be involved in 
cerebral edema development in various animal models of stroke and TBI (Shenaq 
et al. 2012; Akdemir et al. 2014; Katada et al. 2014). At present there are no 
known AQP4 activators or inhibitors, however knock-out mouse lines 
demonstrate reduced infarct size following ischemia (Katada et al. 2014). 
Cytotoxic edema not only disrupts neurons and glia cells but also ultimately 
affects the permeability and structure of the BBB. Vasogenic edema occurs 
following BBB disruption and this leads to leakage of water that is accompanied by 
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plasma proteins and electrolytes into the brain parenchyma (Unterberg et al. 
2004; Khanna et al. 2014). The regulation of matrix metalloproteinase expression 
and activation is complex and tightly controlled, and loss of this control has been 
identified as potentially playing a critical role in the pathophysiology of the BBB in 
stroke and TBI (Seo et al. 2012; Chaturvedi and Kaczmarek 2014). However, there 
is still limited knowledge regarding the complex interaction between BBB damage, 
secondary brain injury and their temporal relationship. 
 
5.3. Neuronal structural changes 
Neurons have a complex and highly polarized morphology. Pathological events at 
cellular and tissue levels affect neuronal morphology. Perhaps the earliest 
structural changes in the ischemic core or trauma foci can occur within the first 
minutes of ischemic and traumatic brain injury. Dendrites are particularly 
vulnerable to injury possibly due to their high concentration of excitatory 
glutamate receptors. Dendritic injury are seen as “beads-on-a-string”, focal 
swellings along the dendritic arbor separated from each other by thin segments 
(Olney, Fuller, and De Gubareff 1979; Ikonomidou et al. 1989; Shengxiang Zhang 
et al. 2005). These structural changes have been called “blebbing” or “beading” of 
dendrites to describe a gross structural change and distinguish it from with the 
localized swelling -“varicose” typical of normal dendrite structures. Presently, 
dendritic blebbing is a well-studied attribute of neuronal pathology and has been 
found following different pathologies like ischemia (Hori and Carpenter 1994; 
Zhang et al. 2005), brain trauma (Castejón 1998; Sword et al. 2013), epilepsy 
(Wong and Guo 2013) and even in Parkinson’s (Mattila et al. 1999) and 
Alzheimer’s diseases (Dickson and Vickers 2001; Hall et al. 2000). Dendritic 
blebbing was first described by Cajal and recognized as a fixation artefact (García-
López, García-Marín, and Freire 2007). For a long time the nature of blebbing 
remain unclear in electron microscopy studies. Morphological abnormalities in 
dendrites have been observed in cultured neurons (Hasbani et al. 1998; Ikegaya et 
al. 2001; Park, Bateman, and Goldberg 1996) and in acute brain slices (Obeidat, 
Jarvis, and Andrew 2000) by the means of Golgi staining and membrane-bound 
dyes following glutamate treatment and oxygen-glucose deprivation. Finally, blebs 
were confirmed to be a real morphological changes (and unlikely to be artifacts) in 
response to pathological stimuli in a series of in vitro and in vivo studies (Obeidat, 
Jarvis, and Andrew 2000; Kirov et al. 2004; Andrew et al. 2007; Zhang and Murphy 
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2007; Brown, Wong, and Murphy 2008; Murphy et al. 2008; Liu and Murphy 2009; 
Risher et al. 2010) that recruit two-photon microscopy and genetically modified 
mice that express GFP (Feng, Mellor, and Bernstein 2000), known for its 
remarkable stability over a wide pH range. 
There are several mechanisms proposed to describe dendritic blebbing. The 
formation of blebs can result from osmotic shock initiated by anoxic 
depolarization following primary ischemic or traumatic impact. It has been shown 
in vitro during excitotoxicity that hyperosmotic saline can prevent dendritic 
blebbing whereas an increase the intracellular concentrations of Na+ and Cl-, but 
not of Ca2+ (Hoffmann and Dunham 1995), causes fast morphological changes 
(Greenwood et al. 2007). Structural studies indicate that cytoskeleton 
perturbations, like loss of microtubule-associated protein 2 (Matesic and Lin 
1994), can be accompanied with bleb formation (Purpura et al. 1982; Gisselsson, 
Matus, and Wieloch 2005). Presently, dendritic blebbing is generally considered as 
an early feature of neuronal dysfunction that precedes cell death (Takeuchi et al. 
2005). Although histological studies demonstrate co-localization of blebs with 
apoptotic and necrotic markers (Enright, Zhang, and Murphy 2007), the power of 
dendritic beading as indicator of neuronal cell fate is questionable because of its 
reversible nature. Alternatively, dendritic blebbing can be recognized as an 
adaptation or a cellular protective mechanism that localizes the consequences of 
ion stress and excitotoxicity, thereby protecting the rest of the neurons. However, 
in this case the surviving neurons would compromised synaptic transmission until 
they regain their dendritic morphologies as blebs disrupt signal propagation (Li 
and Murphy 2008). 
Cell swelling is also a common feature following ischemic and traumatic brain 
injury (Steiner et al. 2012; Jayakumar et al. 2014). It is usually accompanied with 
loss of brain interstitial space. Ultrastructural studies have demonstrated the 
clumping of nuclear chromatin, mitochondria cristae remodeling, microtubule 
disruption and ribosome detachment from the endoplasmic reticulum in the 
swollen cell, preferentially in astrocytes (Jenkins, Becker, and Coburn 1984). Later 
as cellular damage progresses further (Wei et al. 2004), it is possible to detect in 
the electron micrographs flocculent densities in mitochondria indicating calcium 
overload, and also lysosome ruptures that precede catastrophic autolysis and 
necrosis (Hawkins et al. 1972). However, at the same time astrocytes and 
microglia cells do not exhibit any features of apoptosis and necrosis, instead 
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numerous cytoplasmic vacuoles can be found, probably indicating the activation 
of glial cells (Aggoun-Zouaoui et al. 1998). 
Morphological abnormalities  such as dendritic blebbing and astrocyte swelling in 
penumbral and perifocal tissue occur simultaneously with PIDs and CSD 
propagation (Murphy et al. 2008; Risher et al. 2010; Sword et al. 2013). A minimal 
level of blood flow appears to be necessary in order to maintain structural 
integrity and prevent the onset of blebbing; however, ionic stress during PIDs and 
CSD is sufficient to trigger reversible blebs formation (Murphy et al. 2008; Risher 
et al. 2010). Notably, several iterations of rapid dendritic morphology recovery 
after blebbing result in the formation of persistent blebs reflecting the 
accumulation of PIDs-induced damage. Hence, irreversible dendritic abnormalities 
can be consider in penumbral and perifocal tissue as an indicator of the final steps 
during transition towards the infarct core. The reported CSD effects on dendritic 
morphology in health normoxic tissue are highly variable (Takano et al. 2007), but 
they do not probably induce long-lasting dendritic injury (Sword et al. 2013). 
 
5.4. Mitochondria dysfunction 
Substantial experimental evidences from in vitro and in vivo animal models of 
stroke and TBI indicate that mitochondrial dysfunction plays a key role in the 
pathophysiology of acute neurodegeneration (Kushnareva et al. 2005). 
Mitochondria dysfunction is typically heterogeneous and can occur both in the 
acute and sub-acute phases of ischemic and traumatic injury. 
Early classic ultrastructural studies (Lehninger 1962; Blondin and Green 1969; 
Dodson et al. 1974; Garcia et al. 1978; Petito 1986; Pluta and Gajkowska 1984) 
have demonstrated that mitochondrial morphology is altered following ischemic 
brain injury. Mitochondria are found to be moderately or severely swollen, many 
of them exhibit an electron-lucent matrix and some have poorly defined or dilated 
cristae. Mitochondrial swelling is a hallmark ultrastructural change occurring after 
cerebral ischemia and it is recognized as the earliest sign of cell damage (Solenski 
et al. 2002; Radenovic et al. 2011). In vitro assessment of mitochondrial swelling 
by means of light scatter is widely performed in suspensions of isolated 
mitochondria. Our present knowledge about brain mitochondrial swelling has 
been derived from observations in suspensions of isolated mitochondria 
containing both neuronal and glial mitochondria (Malamed 1964; Lifshitz et al. 
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2003; Nukala et al. 2006; Li et al. 2014). From this type of experimental 
preparation it has been suggested that swelling has a colloidal-osmotic nature 
when it is triggered by Ca2+. In addition, it has been shown that mitochondrial 
volume and shape is regulated by K+-fluxes (Blondin and Green 1969). Changes in 
mitochondrial morphology is often recognized as one of the most important 
indicators of the opening of the mitochondrial permeability transition pore 
(mPTP) (Hunter, Haworth, and Southard 1976). This pore is composed of the inner 
membrane adenine nucleotide translocator, the outer membrane voltage-
dependent anion channel and matrix cyclophilin D. The formed pore is permeable 
to molecules less than 1500 Daltons and allows these to flow freely between the 
cytoplasm and mitochondrial matrix. mPTP contributes to the release of 
apoptosis-inducing molecules and to metabolic failure of mitochondria (Zoratti 
and Szabò 1995; Halestrap 1989). Induction of the mPTP might transform 
mitochondria from elongated to rounded structures (Brustovetsky, Li, and 
Brustovetsky 2009) and disrupt their interactions with other intracellular 
elements, for example, with the cytoskeleton (Rintoul et al. 2003). 
Mitochondria dysfunction is well-studied in excitotoxicity by the means of 
fluorescence microscopy. The exposure of cortical neurons to glutamate results in 
a massive intracellular increase of Ca2+ (Abramov and Duchen 2008; Pivovarova 
and Andrews 2010), rapid inhibition of oxidative ATP production, mitochondrial 
Ca2+ overload and depolarization of mitochondrial membrane potential (Starkov, 
Chinopoulos, and Fiskum 2004; Halestrap 2006). Notably, Ca2+ uptake is mediated 
by a ruthenium-red-sensitive uniporter located in the IMM (Nicholls and Budd 
2000) and it is driven by a mitochondrial membrane potential (180mV). Several 
approaches like mild uncoupling (Shabalina and Nedergaard 2011) have been 
utilized to manipulate mitochondrial membrane potential in regard to intracellular 
Ca2+ regulation in neurons. Presently, a physiologically relevant therapeutic 
strategy is a subject of ongoing research. Along with homeostatic and metabolic 
changes, mitochondria exhibit disruption in motility and morphology during 
excitotoxicity. 
Mitochondrial movement in axons and dendrites have been found to be impaired 
following Ca2+ elevation (Chang and Reynolds 2006). Although 30–50% of 
glutamate-treated neurons proceed to apoptosis, mitochondria recover their 
motility in proximal axons within minutes and in dendrites within hours (Rintoul et 
al. 2003). Mitochondria arrest has been shown to be accompanied by significant 
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change in mitochondrial shape from an elongated to a rounded/fragmented shape 
(Isaev et al. 1996; Rintoul et al. 2003; Pivovarova et al. 2004; Greenwood and 
Connolly 2007; Brustovetsky, Li, and Brustovetsky 2009). Typically, alterations in 
mitochondrial morphology take the form of fragmentation. This is likely to be a 
protective response when fragmented mitochondria are utilized by mitophagy or 
pathological when the OMM is ruptured or the mPTP opens leading to toxic 
consequences. These live cell microscopy data have been confirmed by 
ultrastructural studies that demonstrate swelling of mitochondria following 
glutamate treatment in cortical neurons (Sohn, Kim, and Gwag 1998) and in HT4 
cell line derived from hippocampal neurons (Tirosh et al. 2000). There are lines of 
evidence suggesting that mitochondria can spontaneously undergo reversible 
remodeling (Shalbuyeva et al. 2006). Glutamate-dependent mitochondria arrest 
can be mimicked just by blocking OXYPHOS with respiratory chain inhibitors 
(Rintoul et al. 2003). The remodeling of mitochondrial morphology, such as 
shortening and rounding, has been reported to be dependent either upon specific 
Ca2+ influx through NMDA receptors (Rintoul et al. 2003; Pivovarova et al. 2004) or 
upon Na+-driven water influx (Greenwood and Connolly 2007). Moreover, it has 
been proposed that the collapse of mitochondrial membrane potential can by 
itself trigger swelling and other ultrastructural changes in mitochondria. In 
addition, glutamate application to cultivated cells can causes swollen varicosities 
to form in the cytosol, which could influence mitochondrial morphology 
(Greenwood et al. 2007). These two events are connected temporally, spatially 
and functionally in vitro following glutamate application. However, the 
mechanistic details and functional consequences of this phenomenon remain 
unclear. 
Much evidence has been obtained in vitro suggesting that the opening of the 
mitochondrial permeability transition pore (mPTP), which induces matrix swelling 
with inner membrane remodeling and eventual outer membrane rupture, both 
result in the release of apoptogenic proteins. The key molecule released from 
mitochondria is cytochrome c (Li et al. 1997; Green and Reed 1998), which forms 
an apoptosome complex in association with apoptosis protease-activating factor 
1. Further, it activates procaspase-9 followed by proteolytic caspase cascade. 
Other IMS pro-apoptotic proteins, like Smac/DIABLO and Omi/HtrA2, antagonize 
inhibitors of caspases, thus facilitating apoptosis progression (Du et al. 2000; 
Srinivasula et al. 2001; Hegde et al. 2002). Moreover, several proteins released 
from mitochondria, such as apoptosis inducing a factor and endonuclease G, can 
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mediate DNA fragmentation and chromatin condensation in a caspase-
independent manner (Li, Luo, and Wang 2001). Thus, mitochondria are a hub of 
apoptosis signaling during excitotoxicity. There are relatively few reports on 
altered mitochondrial activities following traumatic brain injury. There is general 
support for the hypothesis generated from the ischemia literature on early 
mitochondrial alterations is relevant to the pathogenesis of delayed neural cell 
death and can be directly applied to traumatic brain injury situation (Lifshitz et al. 
2003). 
Ameliorating mitochondrial dysfunction, and specifically inhibition of mPTP 
opening, has been suggested as a protective strategy against ischemic and 
reperfusion injury (Halestrap 2006), although its exact role, contribution to the 
injury and timing are unclear. In vitro studies on primary cultivated neurons 
suggest that mitochondrial dysfunction is induced by glutamate excitotoxicity and 
occurs during ischemia onset (Abramov and Duchen 2008). However, there is 
other evidence for the neuroprotective action of mitochondria protecting 
component cyclosporin A (CsA), which suggests that mitochondrial dysfunction 
occurs during reperfusion or after a period of ionic stress (Domañska-Janik et al. 
2004). 
In animal models of stroke and TBI, mitochondria dysfunction has been manly 
addressed using end point histological and biochemical approaches (Schinzel et al. 
2005; Matsumoto et al. 1999). To the best of our knowledge, no longitudinal 
studies that monitor neuronal mitochondrial morphology within living brain have 
been performed during and following ischemic or traumatic brain injury. 
Previously, less direct methods such as NADH fluorescence (Mayevsky and Chance 
2007) and rhodamine 123 fluorescence (Liu and Murphy 2009) time-lapse imaging 
have been used to monitor onset and acute changes in mitochondria following 
ischemia. This approaches allowed to report for the first time the in vivo dynamics 
of mitochondria depolarization with high temporal and spatial resolution as well 
as to demonstrate the effects of CsA treatment. 
Mitochondrial calcium overload and subsequent dysfunction remain to play an 
important role in the pathology progression and affect post-injury recovery, thus 
raising interest in this process as a target for novel treatments in stroke and TBI. 
However, the underlying mechanisms are controversial and their relevance to in 
vivo conditions remains unknown. Future research should be aimed at 
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understanding when and where mitochondrial dysfunction actually occurs in 
stroke and TBI, and how it can be rescued. 
 
5.5. Reperfusion injury 
In a clinical situation, reperfusion of thrombus-occluded arteries within 1-6 hours 
after stroke onset can be promoted by the means of tissue plasminogen activator 
(Khatri et al. 2009). In ischemic stroke cases where thrombolysis is not applicable, 
spontaneous reperfusion can occur and its rate increases gradually with time. 
Accordingly, 80% of patients with cortical infarcts exhibit reperfusion within the 
first 2 weeks after a stroke (Barber et al. 1998; Jorgensen et al. 1995). These 
clinical situations have been mainly addressed in transient MCAO and 2-VO animal 
models. 
The duration of ischemia is the key factor that determines the outcomes of the 
reperfusion. If global ischemia lasts for 1-2 minutes or transient MCAO for 2.5-30 
minutes and is followed by adequate reperfusion, the cellular metabolism 
gradually normalizes with subsequent recovery of ion gradients across the plasma 
membrane (Ekholm et al. 1993; Pedrono et al. 2010). Reperfusion after prolonged 
global (10-15 min) or focal (30 min, 1h and 2h) ischemia is accompanied by 
multifocal hypoperfusion, known as a “no-reflow phenomenon” (Ames et al. 
1968; Hase et al. 2012; Bai and Lyden 2015). Recently, it has been suggested that 
pericyte constriction contributes significantly to long-lasting decrease in blood 
flow as well as BBB disruption following reperfusion (Yemisci et al. 2009; Hall et al. 
2014). Blood flow is markedly reduced (30-50% of normal flow) for 6-24 hours 
after 10 minutes global ischemia, and the brain tissue remains metabolically 
compromised in this time (Crumrine and LaManna 1991). Even when the supply of 
oxygen and metabolites returns to their normal states, the process of cell damage 
continues. 
Reperfusion injury is mainly driven by secondary excitotoxicity, vasogenic edema 
and inflammation. Although extracellular glutamate concentration has been found 
to reduce rapidly (Benveniste et al. 1984), there are several lines of evidence 
which suggest delayed glutamate release (Phillis, Song, and O’Regan 1997; Lang et 
al. 2011). Moreover, administration of glutamate antagonist after reperfusion 
onset has been shown to prevent ion gradient impairment, CSD and cell death 
(Sakowitz et al. 2009; Eikermann-Haerter et al. 2015). Reperfusion can 
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significantly promote mitochondria dysfunction via Ca2+  overload and 
mitochondria fragmentation mediated by the upregulation of the cyclophilin D 
protein, mitochondrial membrane potential failure or by free radical damage (Li et 
al. 2012). With blood flow recovery, the immune system is heavily triggered by the 
release of cytokines and cell death-associated molecular patterns (Lambertsen, 
Biber, and Finsen 2012). Leukocytes actively influx into the ischemic area and 
facilitate the inflammatory response. In addition, they can initiate re-occlusion of 
the vessels thus contributing significantly to reperfusion injury. Furthermore, 
reperfusion can cause microhemorrhages and vasogenic edema since endothelial 
cells, pericytes and astrocytes are injured or killed during the ischemia episode 
(Heiss 2012). Thus, even after successful thrombolysis or recolonization, 
pathological processes can continue and lead to poor outcomes. 
 
5.6. Gliosis 
The ability to repair brain damage following ischemic and traumatic injury mainly 
determines long-term outcomes. Although the brain has a limited capacity to 
regenerate, tissue repair and replacement by proliferation and local migration of 
cells as well as spontaneous dendrite and axon sprouting take place 
approximately 1 – 2 weeks in animal models of stoke and TBI. However, this 
process typically fails due to an inhibitory environment promoted by gliosis and 
chondroitin sulfate proteoglycans (Silver and Miller 2004; Burda and Sofroniew 
2014). 
The main cell types involved in attempts to quickly restore homeostasis in injured 
tissue are astrocytes, microglia, and NG2-positive oligodendrocyte progenitor cells 
(Fawcett and Asher 1999). Furthermore, in injuries with damaged meninges, 
several connective tissue cells are recruited. Typically, part of the response is 
referred to as astrocytes activation and called reactive gliosis or astrogliosis (Eng 
and Ghirnikar 1994; Sofroniew and Vinters 2010). Reactive astrogliosis in the adult 
brain is generally characterized by morphological changes in astrocytes as well as 
by upregulation of intermediate filament proteins like glial fibrillary acidic protein 
(GFAP) and vimentin (Eng 1985; Pekny et al. 1999; Brenner 2014). It has been 
suggested that propagation of these changes in astrocytes are mediated by 
signaling via gap junctions (Gangoso et al. 2012) and accompanied by altered 
expression of many proteins (Rosario Hernandez et al. 2002; Zamanian et al. 
62 
2012). In severe injuries reactive astrogliosis is accommodated with hypertrophy 
of astrocyte processes and expression of another intermediate filament proteins 
like nestin and synemin (Eliasson et al. 1999). These intermediate filaments are 
routinely used as astrogliosis markers (Ostergaard and Jensen 2013). Reactive 
astrocytes react differently to an injury (Milos Pekny and Nilsson 2005; Sofroniew 
2009), some become hypertrophic or polarized toward the lesion site while 
others, preferentially juxtavascular astrocytes (Bardehle et al. 2013), proliferate 
and migrate to the injury border. Probably, to isolate damaged tissue form the 
healthy ones, a glial scar is formed from hyperfilamentous astrocytes that are 
tightly packed. Glial scars are characterized by limited extracellular space and 
many gaps and tight junctions between neighbor astrocytes that form a physical 
border (Fawcett and Asher 1999; Silver and Miller 2004). 
Reactive astrocytes are known to be a major source of CSPGS following ischemic 
and traumatic brain injury (McKeon et al. 1991). Several growth factors and 
cytokines stimulate expression of ECM proteins, like CSPGS, mainly aggrecan, 
brevican, neurocan, versican and phosphacan (McKeon, Jurynec, and Buck 1999; 
Jones, Margolis, and Tuszynski 2003), semaphorin 3 (De Winter et al. 2002) and 
ephrin-B2 (Bundesen et al. 2003). These strongly modify the composition of the 
interstitial matrix (Fitch and Silver 2008). Altered ECM following ischemic and 
traumatic brain injury has been implicated as an inhibitory environment which 
triggers dystrophic end bulb formation on the end terminal of the regenerating 
axon (Steinmetz et al. 2005; Sharma, Selzer, and Li 2012). Several approaches 
have been tested in vitro and in animal models of stroke and TBI to promote axon 
regeneration. Some of them try to improve neuron capability in regeneration, 
others are aimed to remove an inhibitory environment by eliminating the 
astrocytes that produce them (Moon et al. 2000), blocking CSPGs synthesis, 
secretion and activity (Logan et al. 1994), or by degradation of chondroitin sulfate 
chains by chondroitinase ABC treatment (Zuo et al. 1998). 
The reactive gliosis and glial scar formation is the natural environment which 
effectively handles sub-acute pathology and preserves tissue from the speeding 
injury, thus supporting spontaneous recovery that occurs to some extent (Rolls, 
Shechter, and Schwartz 2009). Nevertheless, it is accompanied by regeneration 
inhibitory effects. Proper modulatory interventions that are applied within 
optimal time windows can be beneficial for broad a spectrum of acute 
neurodegenerative disorders.  
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AIMS 
 
The thesis work was undertaken to: i) determine whether there are fine 
morphological alterations within a living brain during and following ischemic and 
traumatic injury; and ii) exam novel recovery-promoting strategies aiming to 
overcome the inhibitory environment of the altered extracellular matrix. 
 
The specific aims of study were: 
I. To establish and validate the in vivo two-photon microscopy-based on:  
- an animal model of acute brain injury (Study I) 
- automatic analysis for neuronal mitochondrial morphology (Study IV) 
- an approach for awake head-fixed recordings (Study VI) 
II. To examine HB-GAM effects on dendrites plasticity/recovery following acute 
brain injury (Study II) 
III. To study mitochondrial dysfunction in animal and in vitro models of acute 
neurodegenerative disorders as promising drug targets (Studies III and V). 
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METHODS 
The detailed descriptions of the methods used in this thesis work are given in the 
“Materials and Methods” sections of the original publications. All compounds and 
equipment suppliers, catalog numbers and other information as well as recipes of 
solutions are indicated in the original publications. A brief description of the 
methodological approaches is given below. 
 
1. Primary cortical astrocyte cultures (study III) 
For intracellular Ca2+ and mitochondrial morphology and for their motility imaging 
experiments, primary hippocampal and cortical astrocytes were obtained from 2-
4-day-old Wistar rat pups. Cells were dissociated with enzymatic treatment and 
plated on pre-coated glass-bottom 35 mm Petri dishes, and then cultured for 1–
1.5 weeks. To visualize mitochondria, astrocytes were transfected by means of 
lipofectamine reagent with plasmids that encode either mitochondria-targeted 
yellow (mitoYFP) or red (mitoDsRed) fluorescent protein. Next day, DMEM was 
replaced with the standard extracellular solution, which was continuously 
perfused during imaging experiments. [Ca2+]i was measured using the fluorescent 
Ca2+ indicator Fura-2 AM. 
 
2. Treatment and imaging (study III) 
To mimic physiological and pathological increases in [Ca2+]I, ionomycin at either 1 
μM or 5 μM concentration was applied to astrocytes over 2 minutes. For 
disruption of microtubules or actin filaments, astrocytes were incubated with 10 
μM nocodazole or 2.5 μM Latrunculin B, respectively.  
Cultured astrocytes were investigated using (i) a wide-field epifluorescence 
microscope that was equipped with a 175 W xenon lamp, 60X oil-immersion 
objective and a CCD camera, or (ii) confocal laser scanning microscope equipped 
with a 63x water-immersion objective, argon (488 nm) and diode-pumped solid-
state (561 nm) lasers. Images were acquired every 10 s in a time-lapse mode. To 
achieve physiological temperatures and to improve focus stability, the microscope 
frame and the culture dish mounted on it were maintained at a constant 
temperature of 37 °C. 
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3. Experimental animals and surgical procedures (studies I, II, IV, V and VI) 
The local authority (ELÄINKOELAUTAKUNTA-ELLA) approved the animal licenses 
(ESAVI/2857/04.10.03/2012 and ESAVI/11326/04.10.07/2014) that included all 
the procedures used in this study. The mice and rats were bred and kept in group 
cages in the certified animal facility of the University of Helsinki and provided with 
ad libitum food and water. Newborn (P2-P4) Wistar rat pups, C57BL/6J mice at 
ages ranging from 2 to 5 months were used in this study. In addition, the present 
study utilizes the following commercially available transgenic mouse lines that 
express fluorescent proteins in: 
i) neuronal mitochondria; Thy1-mitoCFP mice (Misgeld et al. 2007); 
ii) neurons; Thy1-YFP(H) mice (Feng, Mellor, and Bernstein 2000);  
iii) neuronal mitochondria and neuronal cytoplasm; Thy1-GFP(M) × Thy1-
mitoCFP mice; 
iv) astrocytes; GFAP-EGFP mice (Nolte et al. 2001);  
v) microglia; CX3CR1-EGFP mice (Jung et al. 2000). 
During operations and all experimental procedures, the mice were allowed free 
access to room air and were anaesthetized (i.p.) with a mixture of ketamine (80 
mg/kg) and xylazine (10 mg/kg). To maintain the depth of anesthesia, 
physiological parameters were assessed by using a pulse oximeter equipped with 
a mouse thigh sensor. A heating pad was used to maintain the animals’ core 
temperature at 37 °C. Anaesthetized rodents were prepared for in vivo two-
photon microscopy by implanting either an acute or chronic cranial window 
(Holtmaat, Bonhoeffer, and Chow 2009) or by skull thinning (Guang Yang et al. 
2010). Two-photon imaging sessions were performed after 21-40 days recovery 
period following cranial window implantation or during the first week after skull 
thinning. 
 
4. Immunohistochemistry and Western blotting (study II) 
Animals were perfused with chilled PBS and 4% paraformaldehyde (PFA). The 
brains were then postfixed in 4% PFA overnight at +4 °C. After sinking in 30% 
sucrose, the brains were frozen at -80°C and 25μm thick coronal sections were 
cut. The slices were collected and stored at –20 °C in a cryoprotective solution. 
Double staining with anti-recHB-GAM or anti-pleiotrophin and anti-GFAP 
antibodies was done on floating sections. Alternatively after postfixation, brains 
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were embedded in paraffin and 5-7 25μm thick coronal sections were cut. To 
identify apoptosis, nuclear DNA fragmentation was measured by means of TUNEL 
staining, preformed accordingly to the supplier’s protocol. 
For western blotting, blood from cranial vasculature was washed by transcardiac 
perfusion with chilled PBS. A piece from the cortex was then cut and used for 
sample preparation. Proteins were separated on SDS-PAGE and blotted to 
nitrocellulose membranes. The membranes were used to measure the protein 
levels with anti-recHB-GAM and anti-GAPDH antibodies. 
 
5. In vivo two-photon microscopy (study I, II, IV, V, VI) 
Animals were imaged with laser-scanning two-photon microscope equipped with 
a 25X water immersion high NA objective and femtosecond laser. To achieve 
stable imaging and precise repositioning between imaging sessions, the animals 
were placed under the microscope by attaching the metal holder to the custom-
built frame fixed to a motorized stage. The laser power required for image 
acquisition was adjusted to the lowest possible level for each animal. One imaging 
field of XYZ-stacks for large scale images comprises 500 x 500 μm (for high 
resolution - 165 x 165 μm) in the XY axes. Image stacks were collected with a 
vertical step of 0.5-3 μm. For time-lapse imaging of in vivo mitochondria motility, 
either a 100 frame movie of a single optical section or a small z-series were 
acquired every 0.06-2 seconds, or 6 full-depth z-stacks were imaged with a 15 
minutes time interval. Cerebral vasculature was visualized by i.v. injections of 
100μl 2.5% Texas Red 70kDa dextran. The velocity of blood flow was measured 
from repetitive longitudinal line scans along the central axis of capillaries or 
surface arterioles and veins (Nguyen and Nishimura 2011). 
 
6. Traumatic and ischemic models (studies I, II, IV, V) 
A new animal model of open head injury was developed and validated in Study I. 
This prick-injury model was then used to study dendritic damage and regeneration 
in the cerebral cortex (Study II). For the in vivo characterization of the dynamics of 
neuronal mitochondrial morphology during primary and secondary injury and 
during recovery, several animal models of stoke and TBI were adapted and 
accurately followed by two-photon microscopy. Three different injury types of 
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closed-skull TBI (namely - mild photodamage (MPD), focal laser lesion (FLL) and 
Rose Bengal photosensitization (RBPS)), ranging from mild to severe, were 
inflicted inside the somatosensory cortex through a chronic cranial window (Study 
V). Occlusion of CCAs and cardiac arrest were used to induce reversible (Study V) 
and irreversible (Study IV) global ischemia, respectively.  
 
7. Image analysis 
Images were quantified and processed using the following open-source or 
commercial software: ImageJ, Imaris, AutoQuant X3, AnalySIS, ImagePro 5.1 and 
NeuronStudio or Matlab-based BlebQuant and MicroP programs as well as custom 
macros and scripts. 
Prior to analysis of the density of dendritic tufts and the number of apical 
dendrites in Study II, a surface was generated with Imaris to get rid of the blebbed 
dendrites and unspecific speckles. The maximal intensity z-projection of YFP-
labeled dendritic tuft of cortical neurons was taken within the first 120-180 μm of 
cortex. Further, images were converted from grayscale to binary and 
automatically segmented with Otsu’s thresholding method. The density of 
dendritic tufts was calculated as a sum of pixels belonging to dendrites per area of 
injury site, perilesional area or a remote region. For measurement of the number 
of apical dendrites, the brightness and contrast of individual z-slices was 
normalized to a uniform level. Next, we selected and aligned between 7 and 15 
sequential sub-stacks. Apical dendrites were identified within each sub-stack using 
the Imaris ‘surfaces’ tool. The number of apical dendrites in an individual animal 
was calculated as an average normalized number of surfaces. The statistical unit - 
N values refer to the number of independent replications, each of them being 
performed in a different animal. In Study II, data were presented as mean ± SEM. 
For statistical analyses, Mann-Whitney-U test was used since the data did not 
demonstrate normal distribution. 
To quantify the general motility and velocity of astrocytic mitochondria in vitro 
during physiological and pathological [Ca2+]i rises, a sequential image subtraction 
protocol (Kolikova et al. 2006) and semiautomatic tracking were performed (Study 
III). In the same study mitochondrial morphology was analyzed with MicroP 
software (Peng et al. 2011) that automatically classifies mitochondria into six 
subtypes: small globule, large globule, straight tubule, twisted tubule, branched 
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tubule, and loops. The ratios of the mitochondrial subtypes were investigated to 
define the effects of microtubules/actin filaments disruption and different [Ca2+]i 
elevations on mitochondria morphology. Data from individual cells were pooled 
and presented as mean ± SEM. Student’s t-test was used for statistical analysis 
since the data demonstrated normal distribution. 
To quantify morphological changes in neuronal mitochondria, a supervised-
learning-based method was developed. This method was described in details and 
validated in Study IV, and it estimates the degree of fragmentation of neuronal 
mitochondrial populations based on large scale images of cortical tissue. The final 
analysis of mitochondria fragmentation score was performed only in animals with 
confirmed injury and without imaging- and surgery-induced artifacts. For 
statistical analyses, two-tail paired t-test or repeated measures one-way ANOVA 
followed by Bonferroni’s post-tests was used to compare differences in 
mitochondria fragmentation score across time in each experimental group. F-tests 
were used to compare variance in the mitochondria fragmentation score across 
experimental groups at different time points. 
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RESULTS AND DISCUSSION 
Optical methods are actively used to study the structure and function of the CNS. 
The combination of advanced imaging technologies and fluorescent reporters 
offers an opportunity to investigate the role of endogenous signaling molecules 
and subcellular structures in health and disease. In particular, in vivo two-photon 
microscopy (IV2PM) is a unique non-linear optical technology that allows real-
time visualization of cellular and even subcellular structures in deep cortical layers 
of the rodent brain. Several types of cells and organelles can be imaged 
simultaneously by combining different fluorescent markers. 
The concept of two-photon absorption was first described by Maria Goeppert-
Mayer in 1931, then Winfried Denk and co-authors invented laser scanning two-
photon microscopy and described its principle for imaging biological specimens 
(Denk, Strickler, and Webb 1990), and further for in vivo imaging of neuronal 
activity (Svoboda et al. 1997). Since then, in vivo two-photon microscopy has been 
intensively recruited in different areas of biology (Fritjof Helmchen and Denk 
2005; Shih et al. 2012; Ritsma, Ponsioen, and van Rheenen 2014). These advanced 
optical techniques and genetic animal models provide a unique opportunity to 
study and manipulate mitochondria in the intact rodent brain. 
 
1. The role of HB-GAM in dendritic recovery and plasticity following cortical 
injury  
(study I and II) 
1.1. The novel animal model of acute brain injury followed by intravital 
microscopy 
Regeneration following injury is mainly restricted by glial scar and altered ECM. 
Chondroitin sulfate (CS) chains of the CSPGs is a key inhibitory element limiting 
regeneration and plasticity in the adult nervous system as it has been solidly 
demonstrated by chondroitinase ABC treatment. The initial observation by 
Paveliev and co-authors (Study II) revealed that HB-GAM (heparin-binding growth-
associated molecule or pleiotrophin) can overcome CSPG’s inhibitory effect and 
promote neurite outgrowth in vitro. HB-GAM demonstrated efficiency when 
coated with aggrecan as well as when added to culture media after primary 
cortical and hippocampal neurons were already inhibited by the aggrecan matrix. 
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In Study II, we hypothesized that HB-GAM can enhance CNS regeneration and 
plasticity since it binds GAGs with nanomolar Kd (Milev et al. 1998) and is highly 
expressed in the developing brain (Merenmies and Rauvala 1990). To test this 
hypothesis, we attempted to validate HB-GAM effects on dendritic and/or axonal 
regeneration and plasticity in animal models of CNS injury. It is well known that 
HB-GAM actively binds to ECM and it has a long matrix-bound half-life (Dreyfus et 
al. 1998). Taking into account these considerations, we assumed that in the living 
brain HB-GAM diffusion will be limited and the current well-established animal 
models of TBI would not allow us to reach the trauma site efficiently. To address 
this experimental challenge, we have developed a simple, reproducible and 
controlled focal model of brain injury that can be combined with chronic cranial 
window or skull thinning preparations and be followed by two-photon microscopy 
(Study I).  
Our novel open head injury model produces prick-injury by means of stereotaxic 
targeting of a syringe needle into the cerebral cortex. The prick-injury results in 
parenchyma concussion, destruction of capillary networks and in elimination of 
dendrites at the controlled and reproducible volume of the cerebral cortex (Study 
I). As it was observed with in vivo multiphoton microscopy and Thy1-YFP mice, the 
prick-injury induces dendrite blebbing and formation of dendritic retraction bulbs 
in the peri-lesion areas. During the first two-three days the injury spreads further 
and the size of the lesion area increases (Study I). Although the trauma size is 
relatively small, it activates astrocytes in a substantial cortical volume (1-1.5 mm) 
that can be seen by GFAP staining (Study II). In addition, this staining also 
confirmed that prick-injury leads to formation of an inhibitory glial scar.  
In Study I, we have estimated potential injuries induced by a thin glass pipet 
(outlet diameter 20-30 μm) insertion and microinjection. Dendrites expressing YFP 
under Thy1 promoter did not demonstrate any morphological signs of injury like 
blebbing or retraction bulbs 3 hours after to the intact somatosensory cortex was 
given a microinjection of Sulforhodamine-101 dye. Pipet insertion leaves a trace in 
the brain meninges, thus it can be visualized by a second harmonic generation 
signal. To quantify delayed cell death induced by microinjection, TUNEL staining 
was performed 3 days after microinjection of 1.5 μl 0.1M PBS (negative control) or 
2M NaCl (positive control) at the rate of 2 to 5 nl/sec. A few cells were found to 
have DNA strand breaks after the negative control microinjection, in contrast 
more than 94% of cells were TUNEL “+” in a substantial cortical volume following 
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high molar salt injection (Figure 4). Further the toxicities of different HB-GAM 
concentrations (0.1, 1.0 and 10 mg/ml) were tested with TUNEL staining. None of 
the tested concentrations demonstrated significantly increased numbers of TUNEL 
“+” cells. Moreover, microinjection of 1.5 μl of 1.0 mg/ml HB-GAM into the injury 
site did not promote delayed cell death following prick-injury. 
Figure 4. Histological analyses of microinjection-induced injury. A. Cortical sections from 
adult C57Bl mice were processed for TUNEL staining (green) to mark apoptotic cells at 
day 3 post-injection or 3 days after the prick-injury followed by microinjection. Brain 
sections were treated with DNasa I for positive control. DAPI (blue) was used to label cell 
nucleus. Scale bar, 30μm. B. The fraction of TUNEL+ cells were calculated (mean ± SEM) to 
identity apoptosis following the microinjection of different HB-GAM concentrations (0.1, 
1.0 and 10.0 mg/ml). There was no significant difference in number of TUNEL+ cells 
between 0.1M PBS and HB-GAM injected animals. In addition, quantification of TUNEL 
staining did not show significant difference in HB-GAM injected animals after prick-injury 
compare to IgG injected (1.5 μl of 1.0 mg/ml either HB-GAM or IgG). This data indicates 
that HB-GAM at tested concentration did not induce apoptosis in cortex of intact mice 
and HB-GAM microinjection into prick-injury did not promote it further. 
Protein delivery into the brain is one of the challenging problems in modern 
translational neuroscience since the BBB strictly regulates traffic from the blood 
(Pardridge 2012; Yu and Watts 2013). Presently, several techniques that utilize 
nanoparticles, exosomes, liposomes (Ramos-Cabrer and Campos 2013; Stockwell 
et al. 2014), chimeric peptides that promote transferrin receptor-mediated 
transcytosis (Niewoehner et al. 2014) or focused ultrasound-induced opening 
(Konofagou et al. 2012) have been developed to facilitate penetration of the 
proteins through the BBB. Alternatively, proteins can reach the injury site via 
intrathecal, intracerebroventricular or intranasal delivery since epithelial barriers 
permit passive transport from the cerebrospinal fluid. It has been demonstrated 
that proteins diffuse poorly into the brain parenchyma (Aird 1984; Yan et al. 1994) 
since their concentration gradually decreases in the cerebrospinal fluid due to 
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bulk flow (Bulat and Klarica 2011) and active clearance (Xie et al. 2013). However, 
it is hard to estimate how the manipulations required for these techniques will 
affect the activity of such a small protein like HB-GAM. Microinjection is a unique 
method that overcomes several disadvantages of the delivery techniques describe 
above. Direct delivery of substances via microinjection is a well-established way to 
infuse dyes (Garaschuk, Milos, and Konnerth 2006), small compounds and 
proteins (Davidson et al. 2010; Gonzalez-Perez, Guerrero-Cazares, and Quiñones-
Hinojosa 2010), and to perform genetic manipulations of the targeted cells 
(Molotkov et al. 2010; Borrell 2010). Furthermore, microinjections provide 
opportunities to study the local effects of known concentrations of drugs. 
In summary, our animal model of prick-injury assesses key features of the complex 
pathology following traumatic brain injury and can be combined with 
simultaneous local drug or protein application (Study I). 
 
1.2. HB-GAM promotes robust dendritic recovery in vivo (study II) 
In Study II, we examined the time course of injected HB-GAM in the brain tissue 
by means of western blotting. Although, two thirds of injected HB-GAM was found 
to be cleared within the first day after injury, it stayed as non-fragmented 18 kDa 
protein at least until post-injury day 7. In addition, western blotting did not show 
any endogenous production of HB-GAM following prick-injury in the samples from 
control IgG injected animals. Distribution of injected HB-GAM was detected by 
immunohistochemistry. The majority of the protein stays at the injury site 3 hours 
after injection. Notably, at post-injury day 20, injected HB-GAM was found to 
accumulate in the area of the astrocytic glial scar. Similarly to western blot 
analysis, no HB-GAM signal was detected at the site of injury after injection of IgG 
on days 0, 3 or 20.  
Several studies indicated changes in HB-GAM expression following ischemia and 
traumatic CNS injury. It was found to be upregulated in astrocytes, 
oligodendrocytes, and neurons at days 3 and 7 after spinal cord transection in rats 
(Wang et al. 2004). In addition, the mRNA and protein levels of HB-GAM were 
found to increase in the hippocampal reactive astrocytes on day 4 following 
transient ischemia (Takeda et al. 1995). Another study has indicated upregulation 
of HB-GAM in areas of developing vasculature following focal cerebral ischemia 
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(Yeh et al. 1998). In contrast, in our study prick-injury did not trigger HB-GAM 
endogenous production (Study II). 
Dendritic morphology is linked to information processing and in the adult brain it 
remains relatively static. It is known that brain injury dramatically changes 
dendritic complexity (Biernaskie and Corbett 2001), thus affecting the neuron 
circuitry and general brain functioning. In vivo two-photon microscopy allowed us 
to visualize neuronal morphology up to depths 800 μm below the cortical surface. 
We imaged dendrites in the somatosensory cortex 3 hours, 2 days, 20 days and 40 
days following the prick-injury. Analysis of dendritic turf density and number of 
apical dendrites has revealed that HB-GAM significantly enhanced regeneration 
and plasticity of dendrites in the injury site as well as in the perilesional area up to 
3 weeks after the prick-injury. 
Until now, only a few studies have reported structural changes in the dendrites 
following injury. It has been shown that dendrites exhibit spontaneous 
regeneration following branch elimination (Sacconi et al. 2007; Allegra Mascaro et 
al. 2013; Yuryev, Molotkov, and Khiroug 2014) or following focal laser lesion 
(Study V). These small lesions did not activate astrocytes and initiate scar 
formation; injured tissue is thus probably effectively removed by microglia 
dendritic remodeling and there can be free axonal sprouting. In cases of focal 
ischemia, it has been shown that dendrites become highly asymmetric in the peri-
infarct region and turn away from infarction (Brown et al. 2007); these changes 
persisted over 4 weeks (Brown, Boyd, and Murphy 2010). It was found that 
chondroitinase ABC treatment enhances regeneration by increasing the numbers 
of motor and sensory neurons that send their axons and dendrites across the 
injury site in different animal models of the spinal cord (Bradbury et al. 2002; 
García-Alías et al. 2009) and brain injury (Harris et al. 2013) as well as in ischemic 
stroke (Hill et al. 2012; Soleman et al. 2012; Gherardini, Gennaro, and Pizzorusso 
2015). Although chondroitinase ABC treatment promotes structural plasticity, in 
some cases there are no functional outcomes (Harris et al. 2010) or significant 
effects require specific training (García-Alías et al. 2009). Anti-Nogo-A 
immunotherapy also enhances plasticity in the CNS by modulation of the 
inhibitory environment, and displays effective functional regain as a delayed 
treatment in animal models of CNS injury (Gonzenbach et al. 2012) and cerebral 
stroke (Tsai et al. 2011).  
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In Study II, we have demonstrated a novel strategy to enhance plasticity and 
regeneration, which is an alternative to chondroitinase ABC treatment and anti-
Nogo-A immunotherapy. Our approach modifies the CSPG matrix through the use 
of HBGAM and promotes neural regeneration and functional gain. 
 
2. Mitochondria following ischemic and traumatic injury 
2.1. Ca2+- dependent changes in astrocytic mitochondria in vitro (study III) 
Astrocytes regulate actively neuronal functions via glutamate uptake and 
potassium clearance from synapses. Mitochondria in astrocytes not only provide 
ATP, but also significantly contribute to Ca2+-signaling, which is well-known for its 
role in cell-cell communication and in the regulation of neuroactive factor release, 
and the glutamate-glutamine shuttle (Stephen, Gupta-Agarwal, and Kittler 2014). 
In Study III, we observed mitochondria motility and morphology in primary 
cultivated astrocytes during physiological and pathological [Ca2+]i rises. 
Mitochondria in astrocytes in vitro were found to be highly mobile in the resting 
conditions and to interact with microtubules and actin filaments. Mitochondria 
were more aligned with microtubules and their disruption strongly restricted 
mitochondria motility. In contrast, depolymerization of actin filaments did not 
affect either the morphology of mitochondria or their motility. Our results 
demonstrated that during physiological [Ca2+]i elevation astrocytic mitochondrial 
motility was temporarily and partly arrested. To become “anchored”, 
mitochondria require intact actin filaments (Study III). Previous studies have 
shown that rises in [Ca2+]i trigger mitochondria re-localization or trapping near a 
Ca2+ source at the plasma membrane (Rizzuto, Duchen, and Pozzan 2004; Kolikova 
et al. 2006; Genda et al. 2011). Recently, it has been suggested that mitochondria 
motility is regulated by neuronal activity, glutamate transport and Na+/Ca2+ 
exchange. They can accumulate at glutamate transporter - enriched sites of the 
astrocytic membrane (Jackson et al. 2014; Ugbode, Hirst, and Rattray 2014). 
We also demonstrated actin-independent arrest of mitochondria when they 
undergo fragmentation in a Ca2+-mediated manner during pathological [Ca2+]i rise, 
mimicked by astrocytes treatment with 5 μM ionomycin (Study III). Although 
mitochondria remodeling or rounding and fission have been reported in different 
cell types following various of stimuli (Kristal and Dubinsky 1997; Isaev et al. 1996; 
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Rintoul et al. 2003; Pivovarova et al. 2004; Greenwood and Connolly 2007; 
Brustovetsky, Li, and Brustovetsky 2009; Hom et al. 2010), the mechanism of Ca2+-
dependent remodeling of mitochondria is unclear. It has been suggested that Ca2+ 
can activate remodeling via calcineurin phosphatase which then dephosphorylates 
Drp1 – the main regulator protein of mitochondria fission (Cereghetti et al. 2008; 
Cereghetti, Costa, and Scorrano 2010). The role of mPTP in mitochondria Ca2+-
dependent remodeling is under debate since cyclosporin A does not ameliorate 
Ca2+-mediated fragmentation (Tan et al. 2011). Recently, it has been suggested 
that remodeling of mitochondria morphology following [Ca2+]i rise mainly happens 
due to fragmentation, but not via fission and regulation through the ROS-signaling 
mechanism (Deheshi et al. 2015). 
 
2.2. The novel approach for quantification of neuronal mitochondria 
fragmentation in vivo (Study IV) 
Presently, there are only a few in vivo studies of mitochondria. Several well-
established methods to label mitochondria in vitro have been successfully 
transferred to in vivo conditions. A synthetic water-soluble dye Rhodamine 123, 
known as a probe of mitochondrial membrane potential, was applied to the brain 
surface after craniotomy by Ran R. Liu and Timothy H. Murphy (Liu and Murphy 
2009). It’s loading results in ubiquitous labeling of mitochondria within the 
superficial cortical layers. This approach allowed them to monitor mitochondria 
depolarization with high temporal resolution during the onset of ischemia. There 
are several concerns with Rhodamine 123: the dye needs to be delivered into the 
brain via topical application or bulk loading through craniotomy, thus it is hard to 
avoid surgery-induced artifacts; the dye is rapidly (within 1 or 2 days) washed out 
from the cells, restricting the number and duration of imaging sessions; since the 
dye is not cell specific, it is impossible to distinguish between neuronal and 
astrocytic mitochondria. 
Recently, transgenic animal lines with mitochondria-targeted fluorescent proteins 
have become available (Chandrasekaran et al. 2006; Misgeld et al. 2007; Shitara 
and Shimanuki 2010; Kim et al. 2008; Wang et al. 2011). Axonal transport of 
mitochondria has been described in acutely exposed peripheral axons in mice 
during rest and stimulation (Misgeld et al. 2007; Sajic et al. 2013) as well as in a 
mouse model of amyotrophic lateral sclerosis (Marinkovic et al. 2012). Nikic and 
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co-authors (Nikić, Merkler, and Sorbara 2011) used mice with CFP-labeled 
mitochondria in neurons for two-photon microscopy of single mitochondria in 
experimental autoimmune encephalomyelitis and multiple sclerosis. Moreover, 
mitochondria structure and function have been imaged in ex vivo mice kidney 
during ischemia–reperfusion injury or drug toxicity (Hall et al. 2012). Furthermore, 
mitochondria morphology was recorded following application of apoptosis-
inducing drugs in transgenic zebrafish (Kim et al. 2008). In addition, longitudinal 
imaging was performed in “MitoFish” to study mitochondria lifecycle and 
mitochondria axonal transport in a zebrafish tauopathy model (Plucińska et al. 
2012). 
In Studies IV and V, we utilized the Thy1-mitoCFP transgenic mouse strain 
(Misgeld et al. 2007) to study the morphology and distribution of mitochondria 
labeled with CFP fused to the mitochondria targeting sequence. There are two 
major technical challenges of mitochondria in vivo microscopy in Thy1-mitoCFP 
mice. The first one is a low z-axis resolution of in vivo two-photon microscopy that 
hinders proper three dimensional (3D) neuronal mitochondria analyses. To handle 
this in Studies IV and V mitochondria were analyzed in individual optical sections, 
i.e. in two dimensions (2D). The second one arises from the properties of Thy1-
mitoCFP mice. These mice are known for sparse expression of fluorescent protein 
in the cortex (Crowe and Ellis-Davies 2014). In addition, CFP is three times dimmer 
than GFP and it emits light with a lower quantum yield and extinction coefficient 
(Heim, Prasher, and Tsien 1994). Expression patterns and CFP properties require 
higher laser power and longer exposure times to reach adequate signal-to-noise 
ratio. Optical zooming, which provides images at reasonable resolutions for 
mitochondrial morphology analysis, restricts reparative acquisitions since it is 
accompanied by pronounced photodamage (Study V). To minimize imaging-
induced artifacts, neuronal mitochondria image acquisition was adjusted to the 
lowest possible laser power and the exposure time was reduced by increasing the 
size of the image limiting time of the laser spot in the same cortical volume. The 
resulting large scale image contained projections from the cerebral 
microvasculature and tens of the cells with hundreds of neuronal mitochondria. 
However, existing methods for the segmentation of mitochondria, intensively 
used for their morphology analysis in cultured cells (Lihavainen et al. 2012; Peng 
et al. 2011), could not be in the analysis of mitochondria from large scale images. 
This was mainly due to low resolution and signal-to-noise ratio, which did not 
allow accurate segmentation and consequent morphometric analysis. 
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To overcome the limitations of in vivo two-photon microcopy of cortical neuronal 
mitochondria in Thy1-mitoCFP mice, we developed a novel approach to quantify 
mitochondria morphology (Study IV). This automatic method estimates the degree 
of fragmentation of neuronal mitochondrial populations (herein referred to as a 
patch) from large scale images of cortical tissue. To train a model to predict a 
fragmentation score, a supervised learning approach was used. A beta regression 
model was used (Ferrari and Cribari-Neto 2004) since mitochondrial 
fragmentation score is expected to be a continuous quantity in the interval (0,1), 
representing the range from completely intact to completely fragmented 
mitochondria. As explanatory variables for the regression model, we used 
morphometric and texture features extracted from the patch. In addition, to cope 
with the low resolution and signal-to-noise ratio of the large scale images, we  
utilized a Support Vector Machine classifier (Cortes and Vapnik 1995) to 
automatically exclude locations where the mitochondrial phenotype is unclear. 
During the validation procedure, it was found that the method was as reliable as 
an expert manual scoring. In addition, synthetic mitochondria data highlighted the 
minimal requirements of the imaging system for mitochondria fragmentation 
scoring. Furthermore, the method was shown to be sensitive to changes in 
mitochondria morphology triggered by irreversible global ischemia in an animal 
model of cardiac arrest. The results (Study IV) suggested that the method can not 
only detect changes in neuronal mitochondria morphology, but also, it is able to 
quantify the degree of the changes.  
Automatic quantification of in vivo two-photon microscopy data is an urgent 
problem since data manipulations are complicated and even the analysis of a 
single experiment can require significant human and computational resources. 
Previously, the quantification of subcellular organelle and neurites fragmentation 
has been addressed manually. Presently, automatic analysis of dendritic blebbing 
has been reported (Chen et al. 2011). This technique quantifies morphological 
changes in dendrites which is similar to some extent to our case. However, the 
main difference is that the method relies on comparing an image to a reference 
image, where the dendrites are assumed to be intact. Since it is well known that 
mitochondrial morphology varies even between healthy cells, this method is not 
applicable for mitochondria morphology analysis. 
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2.3. Mitochondria damage and recovery in animal models of stoke and TBI 
(Study IV) 
In Study V, the developed method for quantification of mitochondrial 
fragmentation (Study IV) was applied to analyze mitochondria damage and 
recovery in different models of ischemic and traumatic brain injury. Three 
different injury types: mild photodamage (MPD), focal laser lesion (FLL) and Rose 
Bengal photosensitization (RBPS), ranging from mild to severe, were inflicted 
inside the somatosensory cortex through a chronic cranial window. 
MPD was induced in a small volume (typically 165x165x100μm) by exposing the 
tissue to approximately 50-fold higher light energy than during imaging. MPD 
resulted in rapid mitochondrial fragmentation in the high-exposure region. 
Surprisingly, the damage did not extend to the surrounding tissue and recovery of 
mitochondria morphology occurred only 4 days after MPD. When MPD was 
applied to Thy1-YFP(H) mice, it did not induce strong morphological changes, like 
remodeling, blebbing or retraction of apical dendrites in the photodamaged 
region after 2 weeks, but there was a significant decrease of dendritic spine 
density two days after MPD and the number of spines regained to their initial level 
only after day 7. These results emphasized the important role of mitochondria in 
spine maintenance. Mitochondria renewal was accompanied with normalization 
of spine density, supporting previous in vitro findings suggesting that these two 
events are closely related (Li et al. 2004; Wilson, Slupe, and Strack 2013). 
FLL was produced by targeted laser light eliminating individual branches of the 
apical dendrites in a controlled volume (typically 50-100 μm3) of somatosensory 
cortex. FLL resulted in a complete loss of the CFP fluorescence at the lesion site 
and induced mitochondria fragmentation at the perilesion site. Mitochondria 
fragmentation probably happened due to ionic stress since some dendritic 
branches were cut and then one segment degraded whereas others remained 
connected to the soma but their mitochondria were affected by the extracellular 
environment. Spontaneous dendritic regrowth into the lesion site occurred over 
7-14 days and was accompanied by recovery in mitochondrial morphology. This 
type of injury has been often used to test microglia activation that rapidly 
responds with processes extension toward the damaged site (Davalos et al. 2005). 
Apparently, microglia cells effectively remove debris and promote spontaneous 
dendritic regeneration. 
79 
RBPS was achieved by i.v. injection of Rose Bengal followed by exposure to green 
light, after which mitochondrial morphology was monitored sequentially in the 
core and remote areas. RBPS rapidly produced a core with severe mitochondrial 
fragmentation that did not show any recovery over 3 weeks. Some recovery of 
mitochondrial morphology was observed after 3 weeks but only in relatively small 
parts of the remote area. Finally, a dual TG mouse line Thy1-mitoCFP×Thy1-EGFP-
M was used to evaluate the temporal relationship between mitochondrial 
morphology and the dendritic structure during the first 3h after RBPS. 
Interestingly, structural changes in neurons, such as blebbing, were always 
observed with some delay after the mitochondrial fragmentation occurred first in 
response to RBPS. Mitochondria fragmentation can be thus recognized as the 
earliest sign of neuronal damage. 
Additionally, to evaluate neuronal mitochondria morphology sensitivity to 
ischemia and their recovery following reperfusion, in Study V mice underwent 
CCAs occlusion either for 5 minutes or for 8 minutes. The occlusion duration was 
selected based on irreversible global ischemia data from Study IV and according to 
blood flow impairment. Previous reports maintained CCAs occlusion for 15-30 
minutes (Eklof and Siesjo 1972; Pulsinelli, Levy, and Duffy 1982; Smith, Auer, and 
Siesjo 1984; Terashima et al. 1998), whereas here it was demonstrated that 8 
minutes occlusion induced long-term hypoperfusion. In our hands, 8 minutes CCAs 
occlusion had a dramatic effect on the cortical arteries in ketamine/xylazine 
anesthetized mice, which led to irreversible fragmentation of neuron 
mitochondria. Surprisingly, neuronal mitochondria can tolerate brief impairment 
in blood flow and regain their initial structure within minutes. To our knowledge, 
there are no other experimental data demonstrating such fast reversible 
perturbation in mitochondria morphology within a living brain. Earlier studies that 
utilize the same model demonstrated that structural changes in dendritic 
morphology happened during propagating wave of ischemic depolarization and 
[Ca2+]i elevation (Murphy et al. 2008). Moreover, mitochondrial membrane 
potential monitored by the means of in vivo two-photon rhodamine 123 
fluorescence imaging demonstrated for the first time in vivo the dynamics of 
mitochondria depolarization with high temporal and spatial resolution. This 
method demonstrated the effects of CsA treatment on global ischemia (Liu and 
Murphy 2009). Our results amplified the picture of the ischemia onset with 
profound mitochondria fragmentation after the 2nd minute of ischemia induction. 
Taken together, when mitochondria lose their membrane potential and structural 
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integrity in vivo due to energy demand and ionic stress, there is a narrow time 
window when restoring energy supply can rapidly reverse mitochondria 
morphology and function. Notably, from a clinical view point, if emergency 
interventions can guarantee efficient and rapid reperfusion, neurons can be 
supported with internal pro-survival resources that allow normalization of the 
brain’s circuit functioning and as a consequence improvement of the recovery 
processes. 
 
3. Improvement of animal models 
3.1. Anesthetic effects on injury progression 
A broad spectrum of anesthetics is used in animal models for induction of 
ischemic and traumatic brain injury. The high variability in the size of the resulting 
infarct mainly arises from complicated induction procedures that require animal 
immobilization. Anesthetics are widely acknowledged to introduce pronounced 
effects in animal experiments since they are well-known to be neuroprotective in 
a dose-dependent manner (Matchett et al. 2009; Kawaguchi, Furuya, and Patel 
2005). For example, halothane and isoflurane can reduce the size of infarction by 
attenuation of NMDA-mediated excitotoxicity (Miura et al. 1998; Matchett et al. 
2009). Moreover, this type of anesthesia can mask the benefits of certain 
treatments like those recently observed following photothrombotic occlusion of 
cerebral vessels in fully conscious versus isoflurane anesthetized mice (Seto et al. 
2014). Anesthesia also affects neuronal and astrocytic activity (Hentschke, 
Schwarz, and Antkowiak 2005; Kimura et al. 2014; Goltstein, Montijn, and 
Pennartz 2015; Thrane et al. 2012) which induce widespread alterations in brain 
metabolism (Choi, Lei, and Gruetter 2002; Mizuma et al. 2010). 
A mixture of ketamine/xylazine was utilized in the present study for general 
anesthesia. Ketamine is a non-competitive antagonist of NMDA receptors that has 
a neuroprotective effect resulting in the reduction of infarction size in animal TBI 
and stroke models (Hudetz and Pagel 2010). In intact adult brain ketamine rapidly 
increases the formation of new dendritic spines and enhances synaptic function 
(Li et al. 2010). Xylazine is an effective alpha 2 adrenergic receptor agonist that 
depresses neuronal activity, relaxes skeleton musculature and constricts the 
arteries (Cabral et al. 1998). Ketamine/xylazine anesthetized rodents demonstrate 
reduced brain oxygenation that can cause hypoxia, hypercapnia and acidosis 
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(Wixson et al. 1987; Lei et al. 2001). These concerns of general anesthetics should 
be taken into account as a major disadvantage of present animal models utilized 
for preclinical drug research. 
Anesthetics are commonly used to minimize movement artifacts during acute and 
chronic imaging of cells and their subcellular components within living animal. 
There are growing numbers of laboratories that employ in vivo two-photon 
microscopy to study a wide range of processes in translational and fundamental 
research (Perry, Burke, and Brown 2012; Mostany et al. 2015). Although the 
results are highly controlled and biologically relevant, their interpretations should 
always incorporate the action of anesthetics and anesthesia by itself. 
 
3.2. In vivo two-photon microscopy in awake behaving mice (Study VI) 
Molecular and cellular probing of neuronal circuitries during cognitive and 
behavioral tasks can not be performed in anesthetized animals. As cutting-edge 
experimental advances, in vivo microscopy has been implemented for recording 
from awake behaving rodents (Helmchen et al. 2001; Dombeck et al. 2007). Thus, 
this could become the most relevant approach that would overcome anesthesia 
drawbacks and provide high temporal and spatial resolution. 
Presently, there are several approaches for two-photon microscopy imaging and 
patch-clamp recordings that requite head-fixed preparation or miniaturized head-
mounted microscope, fiberscope or amplifiers (Fee 2000; Helmchen et al. 2001; 
Sawinski et al. 2009). The existing solutions for head-fixing preparation range from 
physical restraint (Fujiwara-Tsukamoto et al. 2012) to spherical treadmill 
combination with computer-generated virtual reality (Dombeck et al. 2010). 
In Study VI, we developed a novel approach for in vivo two-photon microscopy 
and/or patch-clamp recording. A head-fixed mouse moved around flat-floored air-
lifted platform and explored its tangible environment under stress free conditions. 
This approach provided firm head fixation that ensures the mechanical stability 
and allows the imaging of fine neuronal morphology and even mitochondrial 
morphology (data not shown) as well as to record single-cell electrophysiological 
activity in awake animals with the same stability as in anesthetized animals (Study 
VI). Moreover, with the air-lifted mobile homecage longitudinal studies can be 
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designed without limitations in duration and frequency of repeated 
recording/imaging episodes. 
Our system provided a new relevant tool for pre-clinical drug research since 
experimental data obtained with this method are not compromised either by 
anesthesia or by constrain-induced stress. Overcoming anesthesia drawback could 
be especially crucial for the improvement of stroke and TBI animal models. Air-
lifted mobile homecage was combined with optical imaging of intrinsic signals or 
fluorescent reporters of intracellular calcium, glutamate and cell membrane 
voltage. More importantly for translational research, clinically relevant techniques 
like MRI, ultrasound and high resolution microPET could be combined with our 
approach to study different aspects of certain diseases and to validate drug 
candidates’ efficacy. 
Finally, this approach was combined with complex behavioral tasks, namely 
habituation-dishabituation and novel smell recognition tasks (Study VI). Although 
animal movement was restricted to two-dimension, the animals exhibited a wide 
range of movements including horizontal locomotion, grooming, whisking, licking, 
nose-poking, skilled front paw movements, and wall touching with their forelimbs. 
All these movements could be used to report behavioral choice in a similar way as 
it has been done previously in sensory discrimination (Verhagen et al. 2007), 
detection (Houweling and Brecht 2008) and virtual navigation tasks (Dombeck et 
al. 2010). The air-lifted mobile homecage could be also utilized in sensorimotor 
system studies with a high level of control over both the stimulation conditions 
and the behavioral read-outs. Furthermore, studies of cognitive abilities in awake 
mice could be performed during conditioning, spatial navigation, decision-making 
tasks and social interactions. 
There are several concerns with head-fixation preparation in general and with this 
method, particularly. First, theoretically there is sensory incongruity due to 
inappropriate activity of the vestibular system during locomotion, however it is 
hard to estimate its “artificial” contribution to neuronal circuitry activity since the 
brain should adapt to head-fixation following a reasonably prolonged 
training/habituation period. Second, the air-lifted mobile homecage provide a 
simple and small space to navigate, thus it could be difficult to study place cell 
activity in this environment. Third, visual or sensory stimulation and reward-based 
experiments would require the design of miniaturized devices that could be 
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challenging for some applications. In addition, the head-fixation preparation is a 
time-demanding approach since it requires sufficient time to prepare an animal 
for the experiment, namely 2-3 weeks of post-operation recovery and 4 days of 
training. 
In summary, we believe that the novel awake animal models could change pre-
clinical practice and increase the efficacy of transitional stroke and TBI research. It 
is expected that this approach will facilitate the biological relevance of studies 
since it allows us to combine cellular, molecular and behavioral levels of 
observation and manipulation within a single experiment. 
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CONCLUSIONS 
 
In this thesis work three novel approaches have been describe and further used to 
study the fine morphology of neurons and neuronal mitochondria during and 
following ischemia and traumatic brain injury. 
By applying our animal model of acute brain injury (Study I) we were able to 
demonstrate that, through the use of an HBGAM, inhibitory extracellular matrix, 
namely CS chains of the CSPGs, can be modulated to enhance regeneration and 
plasticity of dendrites following cortical prick-injury (Study II). 
We studied mitochondria motility and morphology on primary cultured astrocytes 
and demonstrated that: i) the motility of astrocytic mitochondria is inversely 
related to [Ca2+]i; ii) mitochondria require intact microtubules for their motility; iii) 
elevated [Ca2+]i immobilizes mitochondria by strengthening their interaction with 
actin filaments; and iv) an actin-independent arrest of mitochondria may also 
occur during pathological [Ca2+]i rise when they undergo fragmentation (Study III). 
By applying our automatic quantification method (Study IV) we were able to 
confirm that in vivo two-photon microscopy can be utilized for neuronal 
mitochondria analysis in the mice neocortex. Neuronal mitochondria were found 
to be extremely sensitive to laser light exposure and to blood flow interruption. 
Our results identify mitochondrial fragmentation as the earliest ultrastructural 
change in the neuronal damage cascade, which precedes the gross changes in 
dendritic morphology. Interestingly, our data suggest that alterations in neuronal 
mitochondrial morphology can be spontaneously reversible in traumatic and 
ischemic injuries and therefore highlight mitochondria as a potential target for 
therapeutic interventions (Study V). 
Finally, we developed a novel approach for in vivo microscopy and single cell 
recordings in awake head-fixed rodents that can be combined with behavioral 
tasks (Study VI). This “awake microscopy” approach can be further combined with 
quantitative analysis of mitochondrial morphology in traumatic/ischemic injury 
models (Study V). This powerful combination can initiate a novel era of 
mitochondria fundamental research within the awake living brain and help to 
bring translational research to new horizons.  
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